<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN"
                           "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer Berlin Heidelberg</PublisherName>
    <PublisherLocation>Berlin, Heidelberg</PublisherLocation>
    <PublisherImprintName>Springer</PublisherImprintName>
    <PublisherURL>NO</PublisherURL>
  </PublisherInfo>
  <Book Language="En" OutputMedium="All">
    <BookInfo BookProductType="Professional book" ContainsESM="No" Language="En" MediaType="eBook" NumberingDepth="3" NumberingStyle="ChapterContent" OutputMedium="All" TocLevels="0">
      <BookID>978-3-662-44023-0</BookID>
      <BookTitle>Post-treatment Imaging of the Orbit</BookTitle>
      <BookDOI>10.1007/978-3-662-44023-0</BookDOI>
      <BookTitleID>307975</BookTitleID>
      <BookPrintISBN>978-3-662-44022-3</BookPrintISBN>
      <BookElectronicISBN>978-3-662-44023-0</BookElectronicISBN>
      <BookEdition>2015</BookEdition>
      <BookChapterCount>8</BookChapterCount>
      <BookCopyright>
        <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>
        <CopyrightYear>2015</CopyrightYear>
      </BookCopyright>
      <BookSubjectGroup>
        <BookSubject Code="SCH" Type="Primary">Medicine &amp; Public Health</BookSubject>
        <BookSubject Code="SCH29005" Priority="1" Type="Secondary">Imaging / Radiology</BookSubject>
        <BookSubject Code="SCH44004" Priority="2" Type="Secondary">Ophthalmology</BookSubject>
        <BookSubject Code="SCH29056" Priority="3" Type="Secondary">Radiotherapy</BookSubject>
        <SubjectCollection Code="SUCO11650">Medicine</SubjectCollection>
      </BookSubjectGroup>
      <BookstoreLocation>Radiology</BookstoreLocation>
    </BookInfo>
    <BookHeader>
      <EditorGroup>
        <Editor AffiliationIDS="Aff1">
          <EditorName DisplayOrder="Western">
            <GivenName>Daniel Thomas</GivenName>
            <FamilyName>Ginat</FamilyName>
          </EditorName>
          <Contact>
            <Email>ginatd01@gmail.com</Email>
          </Contact>
        </Editor>
        <Editor AffiliationIDS="Aff2">
          <EditorName DisplayOrder="Western">
            <GivenName>Suzanne K.</GivenName>
            <FamilyName>Freitag</FamilyName>
          </EditorName>
          <Contact>
            <Email>suzanne_freitag@meei.harvard.edu</Email>
          </Contact>
        </Editor>
        <Affiliation ID="Aff1">
          <OrgDivision>Director of Head and Neck Imaging, Department of Radiology</OrgDivision>
          <OrgName>University of Chicago</OrgName>
          <OrgAddress>
            <City>Chicago</City>
            <State>Illinois</State>
            <Country>USA</Country>
          </OrgAddress>
        </Affiliation>
        <Affiliation ID="Aff2">
          <OrgDivision>Director, Ophthalmic Plastic Surgery, Service, Department of Ophthalmology</OrgDivision>
          <OrgName>Massachusetts Eye and Ear Infirmary, Harvard Medical School</OrgName>
          <OrgAddress>
            <City>Boston</City>
            <State>Massachusetts</State>
            <Country>USA</Country>
          </OrgAddress>
        </Affiliation>
      </EditorGroup>
    </BookHeader>
    <Chapter ID="b978-3-662-44023-0_8" Language="En" OutputMedium="All">
      <ChapterInfo ChapterType="OriginalPaper" ContainsESM="No" Language="En" NumberingDepth="3" NumberingStyle="ChapterContent" OutputMedium="All" TocLevels="0">
        <ChapterID>8</ChapterID>
        <ChapterNumber>8</ChapterNumber>
        <ChapterDOI>10.1007/978-3-662-44023-0_8</ChapterDOI>
        <ChapterSequenceNumber>8</ChapterSequenceNumber>
        <ChapterTitle Language="En">Imaging After Orbital and Intraocular Oncology Therapies</ChapterTitle>
        <ChapterFirstPage>171</ChapterFirstPage>
        <ChapterLastPage>200</ChapterLastPage>
        <ChapterCopyright>
          <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>
          <CopyrightYear>2015</CopyrightYear>
        </ChapterCopyright>
        <ChapterHistory>
          <RegistrationDate>
            <Year>2014</Year>
            <Month>7</Month>
            <Day>8</Day>
          </RegistrationDate>
          <OnlineDate>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>6</Day>
          </OnlineDate>
        </ChapterHistory>
        <ChapterContext>
          <BookID>978-3-662-44023-0</BookID>
          <BookTitle>Post-treatment Imaging of the Orbit</BookTitle>
        </ChapterContext>
      </ChapterInfo>
      <ChapterHeader>
        <AuthorGroup>
          <Author AffiliationIDS="Aff3">
            <AuthorName DisplayOrder="Western">
              <GivenName>Jeffrey</GivenName>
              <FamilyName>Bonham</FamilyName>
              <Degrees>MD</Degrees>
            </AuthorName>
          </Author>
          <Author AffiliationIDS="Aff4" CorrespondingAffiliationID="Aff4">
            <AuthorName DisplayOrder="Western">
              <GivenName>Daniel</GivenName>
              <GivenName>Thomas</GivenName>
              <FamilyName>Ginat</FamilyName>
              <Degrees>MD, MS</Degrees>
            </AuthorName>
            <Role>Director</Role>
          </Author>
          <Author AffiliationIDS="Aff5">
            <AuthorName DisplayOrder="Western">
              <GivenName>Suzanne</GivenName>
              <GivenName>K.</GivenName>
              <FamilyName>Freitag</FamilyName>
              <Degrees>MD</Degrees>
            </AuthorName>
            <Role>Director</Role>
          </Author>
          <Affiliation ID="Aff3">
            <OrgDivision>Department of Radiology</OrgDivision>
            <OrgName>University of Chicago</OrgName>
            <OrgAddress>
              <Street>5841 S Maryland Avenue</Street>
              <City>Chicago</City>
              <State>IL</State>
              <Postcode>60637</Postcode>
              <Country>USA</Country>
            </OrgAddress>
          </Affiliation>
          <Affiliation ID="Aff4">
            <OrgDivision>Head and Neck Imaging, Department of Radiology</OrgDivision>
            <OrgName>University of Chicago</OrgName>
            <OrgAddress>
              <Street>5841 S Maryland Avenue</Street>
              <City>Chicago</City>
              <State>IL</State>
              <Postcode>60637</Postcode>
              <Country>USA</Country>
            </OrgAddress>
          </Affiliation>
          <Affiliation ID="Aff5">
            <OrgDivision>Ophthalmic Plastic Surgery Service, Department of Ophthalmology</OrgDivision>
            <OrgName>Massachusetts Eye and Ear Infirmary, Harvard Medical School</OrgName>
            <OrgAddress>
              <City>Boston</City>
              <State>MA</State>
              <Country>USA</Country>
            </OrgAddress>
          </Affiliation>
        </AuthorGroup>
        <Abstract ID="Abs1" Language="En" OutputMedium="Online">
          <Heading>Abstract</Heading>
          <Para>A wide variety of benign and malignant neoplasms can affect the orbit, either primarily or secondarily, such as via extension of a tumor from a neighboring structure or as a metastasis. Likewise, there are a multitude of orbital oncological therapeutic modalities available, including surgery, chemotherapy, radiation, cryotherapy, and laser therapy. Diagnostic imaging plays an important role not only in the pretreatment evaluation of orbital region tumors but also for follow-up after treatment in order to monitor tumor response or recurrence. CT and MRI are generally suitable modalities for posttreatment surveillance of the orbit. Positron emission tomography (PET) using [18 F]-2-deoxy-D-glucose (18FDG) serves a role as a staging tool in ophthalmic oncology, particularly for detecting distant metastatic lesions that conventional imaging studies may otherwise miss. Besides the initial workup of orbital tumors, 18FDG-PET can be useful for the assessment of treatment response. Ultrasound with color and spectral Doppler is useful for evaluating small intraocular tumors that are otherwise inconspicuous on CT and MRI. The interpretation of posttreatment imaging can be particularly challenging due to the altered anatomy and tissue properties caused by many forms of treatment. Furthermore, many oncological treatments can cause complications that warrant investigation via diagnostic imaging. Some of these complications have particularly characteristic and interesting imaging findings. In order to optimally approach an imaging study of the orbit after treatment, it is important to know what the original tumor was like, the type and timing of the therapy that was administered, and the clinical status of the patient at the time of the scan. The various types of orbital oncologic treatments and their corresponding expected and complicated imaging features are reviewed in the following sections.</Para>
        </Abstract>
      </ChapterHeader>
      <Body>
        <Section1 ID="Sec1">
          <Heading>Overview</Heading>
          <Para>A wide variety of benign and malignant neoplasms can affect the orbit, either primarily or secondarily, such as via extension of a tumor from a neighboring structure or as a metastasis. Likewise, there are a multitude of orbital oncological therapeutic modalities available, including surgery, chemotherapy, radiation, cryotherapy, and laser therapy. Diagnostic imaging plays an important role not only in the pretreatment evaluation of orbital region tumors but also for follow-up after treatment in order to monitor tumor response or recurrence. CT and MRI are generally suitable modalities for posttreatment surveillance of the orbit. Positron emission tomography (PET) using [18 F]-2-deoxy-D-glucose (18FDG) serves a role as a staging tool in ophthalmic oncology, particularly for detecting distant metastatic lesions that conventional imaging studies may otherwise miss. Besides the initial workup of orbital tumors, 18FDG-PET can be useful for the assessment of treatment response. Ultrasound with color and spectral Doppler is useful for evaluating small intraocular tumors that are otherwise inconspicuous on CT and MRI. The interpretation of posttreatment imaging can be particularly challenging due to the altered anatomy and tissue properties caused by many forms of treatment. Furthermore, many oncological treatments can cause complications that warrant investigation via diagnostic imaging. Some of these complications have particularly characteristic and interesting imaging findings. In order to optimally approach an imaging study of the orbit after treatment, it is important to know what the original tumor was like, the type and timing of the therapy that was administered, and the clinical status of the patient at the time of the scan. The various types of orbital oncologic treatments and their corresponding expected and complicated imaging features are reviewed in the following sections.</Para>
        </Section1>
        <Section1 ID="Sec2">
          <Heading>Intraocular Biopsy</Heading>
          <Para>Biopsy is often performed for the diagnosis of orbital masses. Incisional biopsy, which involves sampling a small portion of a lesion, may be useful when a tissue diagnosis is desired, but the lesion is infiltrative and cannot be separated from surrounding structures. Excisional biopsy consists of removing the tumor in its entirety and is both diagnostic and therapeutic. Aside from absence of the lesion, complete excisional biopsy may leave no changes on postoperative imaging. However, there may be perceptible defects in normal anatomic structures that were removed along with the tumor (Fig. <InternalRef RefID="Fig1">8.1</InternalRef>). In addition, there may be alterations in the structures remaining in the region of the excision due to reconstructive efforts. For example, a vascularized nasoseptal mucosal flap used to reconstruct a medial orbital wall defect created during endoscopic transnasal orbitotomy can demonstrate avid enhancement on MRI (Fig. <InternalRef RefID="Fig2">8.2</InternalRef>), potentially mimicking residual tumor. However, the flap has a distinctive linear configuration with a connection to the nasal septum.
<Figure Category="Standard" Float="Yes" ID="Fig1">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.1</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Excisional biopsy of an anterior segment tumor. The patient has a history of iris melanoma excised many years earlier. UBM (<Emphasis Type="Bold">a</Emphasis>) and corresponding clinical photograph (<Emphasis Type="Bold">b</Emphasis>) show a defect in the iris and ciliary body (Courtesy of Ivana Kim MD)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO1">
                <ImageObject Color="Color" FileRef="MediaObjects/307975_1_En_8_Fig1_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig2">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.2</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Nasoseptal flap. The patient presented with left optic neuropathy due to a cavernous hemangioma in the orbital apex and underwent excisional biopsy via a transnasal endoscopic technique with access through the medial wall of the orbit. Due to the risk of postoperative enophthalmos, the medial wall of the orbit has been reconstructed with a vascularized pedicle flap from the mucosa of the nasal septum. Preoperative coronal post-contrast, fat-suppressed T1-weighted MRI (<Emphasis Type="Bold">a</Emphasis>) shows a well-defined enhancing lesion in the left orbital apex (<Emphasis Type="Italic">arrow</Emphasis>). Postoperative coronal post-contrast, fat-suppressed T1-weighted MRI (<Emphasis Type="Bold">b</Emphasis>) shows linear enhancement along the medial wall of the orbital apex extending from the nasal septum, which corresponds to the transposed mucosal flap (<Emphasis Type="Italic">arrowheads</Emphasis>). The mucosal flap enhances avidly similar to the preoperative appearance of the tumor. However, there was no evidence of residual tumor (postoperative imaging was obtained to confirm complete tumor resection)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO2">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig2_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>Complications related to orbital biopsy that may lead to imaging evaluation are uncommon and include infection, hemorrhage, visual loss, diplopia, and CSF leak. CT and MRI are both appropriate modalities for evaluating postoperative infection, which can manifest as preseptal and/or postseptal cellulitis, with or without abscess. Hemorrhage can occur anywhere along the path of the biopsy, including within or adjacent to the remaining portions of the biopsied tumor, which can result in transient expansion of the mass. Noncontrast CT and MRI are suitable for the evaluation of post-biopsy hemorrhage, in order to characterize the extent and site of hemorrhage. There can be an acute change in the appearance of the tumor if it has hemorrhaged, which can manifest with fluid-fluid levels on CT or MRI (Fig. <InternalRef RefID="Fig3">8.3</InternalRef>). Disruption of the orbital roof during a biopsy can lead to a CSF leak, which can manifest as an accumulation of fluid within the orbit and pneumocephalus. Thin-section, multiplanar CT without contrast is useful for delineating the defect and planning surgical repair, if necessary (Fig. <InternalRef RefID="Fig4">8.4</InternalRef>). Alternatively, an encephalocele can form through the iatrogenic defect and MRI is useful for characterizing this entity prior to surgical repair.
<Figure Category="Standard" Float="Yes" ID="Fig3">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.3</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Post-biopsy hemorrhage. The patient underwent recent left anterolateral orbitotomy for biopsy of a left orbital tumor. Axial T1-weighted (<Emphasis Type="Bold">a</Emphasis>) and T2-weighted (<Emphasis Type="Bold">b</Emphasis>) MR images show a fluid-fluid level within the left orbital mass (<Emphasis Type="Italic">arrows</Emphasis>)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO3">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig3_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig4">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.4</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Post-biopsy CSF leak. The patient underwent recent orbital tumor biopsy. Axial (<Emphasis Type="Bold">a</Emphasis>) and coronal (<Emphasis Type="Bold">b</Emphasis>) CT images show a defect in the right orbital roof and a small amount of pneumocephalus (<Emphasis Type="Italic">arrows</Emphasis>). The biopsy was performed to evaluate for perineural tumor spread involving the supraorbital nerve</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO4">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig4_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
        </Section1>
        <Section1 ID="Sec3">
          <Heading>Enucleation</Heading>
          <Para>Enucleation refers to removal of the eye. The main oncological indications for enucleation include uveal melanoma, retinoblastoma, or other less common intraocular tumors that are large, recurrent, or poorly responsive to treatment. The extraocular muscles are disinserted from the globe prior to its removal from the socket. The muscles may be reattached to the orbital implant in a variety of ways, including suturing muscle to muscle in front of the implant, suturing the muscle directly to the implant, or suturing the muscle to the material used to wrap the implant. The void created by removing the globe is typically filled with an orbital implant (Fig. <InternalRef RefID="Fig5">8.5</InternalRef>). The most commonly used implants are composed of silicone, hydroxyapatite, and porous polyethylene (Medpor). The imaging features of the various implant materials are discussed and depicted in extensive detail in Chap. <ExternalRef>
              <RefSource>5</RefSource>
              <RefTarget Address="10.1007/978-3-662-44023-0_5" TargetType="DOI"/>
            </ExternalRef>. However, notably, certain implants, such as Medpor, can demonstrate internal enhancement due to fibrovascular ingrowth, which should not be mistaken for tumor involvement (Fig. <InternalRef RefID="Fig6">8.6</InternalRef>). Furthermore, in the early postoperative period, enhancement and T2 hyperintensity of the orbital tissues are expected findings (Fig. <InternalRef RefID="Fig7">8.7</InternalRef>) and may represent granulation tissue or a transient inflammation. Although this is a characteristically diffuse process, it can be difficult to discern an underlying tumor, and follow-up imaging is recommended if there is any doubt. Despite the potential artifacts, MRI with contrast is generally the best modality for surveillance imaging after enucleation for retinoblastoma in order to delineate local and regional tumor recurrence, trilateral retinoblastoma, as well as distant metastases to the spine. In addition, intraocular melanoma has a particular propensity to metastasize to the liver (95 % of metastases) and occasionally to the brain (Fig. <InternalRef RefID="Fig8">8.8</InternalRef>). Contrast-enhanced CT and 18FDG-PET are also appropriate imaging modalities for metastatic workup in the bones, chest, and abdomen, depending upon the type of primary tumor and location of the suspected metastasis. For example, melanoma and squamous cell carcinoma tend to be markedly hypermetabolic on 18FDG-PET, unless there is considerable necrosis, while adenoid cystic carcinoma tends to not be so conspicuous. A potential pitfall on 18FDG-PET is the presence of orbital implants. While silicone implants do not appear hypermetabolic on 18FDG-PET (Fig. <InternalRef RefID="Fig9">8.9</InternalRef>), Medpor and hydroxyapatite implants with fibrovascular ingrowth can appear diffusely hypermetabolic (Fig. <InternalRef RefID="Fig10">8.10</InternalRef>) due to physiologic activity. This should not be mistaken for neoplasm or infection, which tends to display a greater degree of hyperpigmentation in components beyond the implant itself.
<Figure Category="Standard" Float="Yes" ID="Fig5">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.5</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Enucleation. Preoperative axial fat-suppressed T2-weighted MRI (<Emphasis Type="Bold">a</Emphasis>) shows a right intraocular mass, consistent with retinoblastoma (<Emphasis Type="Italic">arrow</Emphasis>). Postoperative axial fat-suppressed T2-weighted MRI (<Emphasis Type="Bold">b</Emphasis>) shows interval removal of the right globe and insertion of a silicone implant. Much of the right optic nerve remains</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO5">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig5_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig6">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.6</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Porous polyethylene (Medpor) implant fibrovascular ingrowth and ocular prosthesis artifact. Axial T1-weighted (<Emphasis Type="Bold">a</Emphasis>) and axial post-contrast fat-suppressed T1-weighted (<Emphasis Type="Bold">b</Emphasis>) MR images show expected diffuse enhancement of the Medpor implant (<Emphasis Type="Italic">arrow</Emphasis>). There is also linear enhancement of the conjunctiva surrounding the ocular prosthesis (<Emphasis Type="Italic">arrowheads</Emphasis>)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO6">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig6_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig7">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.7</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Expected early postoperative findings related to enucleation. Initial postoperative coronal fat-suppressed T2-weighted (<Emphasis Type="Bold">a</Emphasis>) and post-contrast fat-suppressed T1-weighted (<Emphasis Type="Bold">b</Emphasis>) MR images show diffuse T2 hyperintensity and enhancement of the orbit surrounding the implant (<Emphasis Type="Italic">arrows</Emphasis>). The corresponding follow-up MR images obtained 6 months later (<Emphasis Type="Bold">c</Emphasis>, <Emphasis Type="Bold">d</Emphasis>) show near interval resolution of these findings, although there is persistent mild enhancement and swelling of the extraocular muscles. A Medpor implant is present</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO7">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig7_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig8">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.8</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Recurrent choroidal melanoma with metastases. Post-contrast fat-suppressed axial (<Emphasis Type="Bold">a</Emphasis>) and coronal (<Emphasis Type="Bold">b</Emphasis>) T1-weighted MR images show an enhancing mass in the right orbit, posterior to the ocular implant. Sagittal post-contrast T1-weighted MRI (<Emphasis Type="Bold">c</Emphasis>) shows an enhancing metastasis in the brain (<Emphasis Type="Italic">arrow</Emphasis>). Coronal post-contrast T1-weighted MRI (<Emphasis Type="Bold">d</Emphasis>) of the abdomen shows a large enhancing metastasis within the liver </SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO8">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig8_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig9">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.9</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Silicone orbital implant on positron emission tomography/CT imaging. The 18FDG-PET/CT fusion image shows absence of hypermetabolism in the left orbital prosthesis (<Emphasis Type="Italic">arrow</Emphasis>)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO9">
                <ImageObject Color="Color" FileRef="MediaObjects/307975_1_En_8_Fig9_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig10">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.10</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Hydroxyapatite implant on positron emission tomography/CT. The 18FDG-PET/CT fusion image shows mild diffuse hypermetabolism within the right orbital hydroxyapatite prosthesis (<Emphasis Type="Italic">arrow</Emphasis>). There were no symptoms related to the implant and there was no evidence of tumor in the orbits</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO10">
                <ImageObject Color="Color" FileRef="MediaObjects/307975_1_En_8_Fig10_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>Besides surveillance of tumor recurrence and metastases, diagnostic imaging is also useful for evaluating complications related to enucleation, which are depicted in Chap. <ExternalRef>
              <RefSource>5</RefSource>
              <RefTarget Address="10.1007/978-3-662-44023-0_5" TargetType="DOI"/>
            </ExternalRef>. However, enucleation during infancy due to retinoblastoma or other causes can lead to the development of microorbitalism due to the decreased growth stimulation from the globe and surrounding soft tissues (orbital arrest syndrome). The ipsilateral maxillary sinus is frequently hypoplastic as well. High-resolution multiplanar facial bone CT imaging (Fig. <InternalRef RefID="Fig11">8.11</InternalRef>) is useful for characterizing the abnormalities and for corrective surgical planning, which may consist of osteotomy and expansion of the orbital vault.
<Figure Category="Standard" Float="Yes" ID="Fig11">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.11</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Orbital arrest syndrome (microorbitalism). Axial (<Emphasis Type="Bold">a</Emphasis>) and coronal (<Emphasis Type="Bold">b</Emphasis>) CT images show a relatively small left orbital cavity, which contains a hydroxyapatite implant. In particular, there is sclerosis and thickening of portions of the left orbital walls. There is also hypoplasia of the left maxillary sinus, which is depicted on the coronal image</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO11">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig11_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
        </Section1>
        <Section1 ID="Sec4">
          <Heading>Exenteration</Heading>
          <Para>Exenteration involves removal of the orbital contents, including the globe and varying amounts of periorbital tissue. Exenteration is a radically disfiguring procedure that is most often reserved for the treatment of life-threatening malignancies arising from the orbit, paranasal sinuses, or periocular skin. The most common diagnoses requiring orbital exenteration include basal cell carcinoma, sebaceous carcinoma, squamous cell carcinoma, melanoma, and lacrimal gland malignancies. There are various classifications of exenteration surgery based on which tissues are removed. For example, Meyer and Zaoli’s classification describes four types of exenteration. In type I, the palpebral skin and conjunctiva are spared. In type II, only the palpebral skin is spared and the globe and its appendages are removed with the conjunctiva. In type III, the eyelid is removed with the orbital contents. In type IV, the globe, eyelids, and appendages of the eye are removed with the involved bony structures. Various methods for reconstruction of the exenteration cavity can be implemented, including partial- or full-thickness skin graft, dermis fat grafts, free or pedicled musculocutaneous flaps, and artificial implants (Figs. <InternalRef RefID="Fig12">8.12</InternalRef>, <InternalRef RefID="Fig13">8.13</InternalRef>, and <InternalRef RefID="Fig14">8.14</InternalRef>). Of note, on postoperative MRI or CT imaging, the viable muscular portion of myocutaneous flaps normally displays enhancement, which should not be mistaken for tumor recurrence. Patients may wear an eye patch following surgery or have an ectoprosthesis that features the globe and eyelids, which are custom fit for cosmetic purposes. The prostheses can be made from a variety of materials, such as polymethyl methacrylate and silicone. These prostheses are retained with adhesives, tissue undercuts, or magnets once the socket has healed. The prosthesis is not always removed during diagnostic imaging exams of the region, which usually does not pose an issue with regard to artifacts since the majority of these do not contain metallic components and the underlying exenteration cavity can be readily delineated (Fig. <InternalRef RefID="Fig15">8.15</InternalRef>).
<Figure Category="Standard" Float="Yes" ID="Fig12">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.12</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Eyelid-sparing exenteration with fat graft reconstruction. The patient had a history of recurrent choroidal melanoma after enucleation. Axial T2-weighted (<Emphasis Type="Bold">a</Emphasis>), T1-weighted (<Emphasis Type="Bold">b</Emphasis>), and post-contrast fat-suppressed T1-weighted (<Emphasis Type="Bold">c</Emphasis>) images show preservation of the eyelids (<Emphasis Type="Italic">arrows</Emphasis>), which are mildly swollen and enhancing due to recent surgery. Fat graft is present within the exenteration cavity</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO12">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig12_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig13">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.13</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Orbital exenteration and maxillectomy with myocutaneous graft reconstruction. The patient has a history of a salivary gland malignancy involving the right orbit. Axial T2-weighted (<Emphasis Type="Bold">a</Emphasis>), T1-weighted (<Emphasis Type="Bold">b</Emphasis>), and fat-suppressed, post-contrast T1-weighted (<Emphasis Type="Bold">c</Emphasis>) MR images show striations and enhancement of the muscular component of the flap (<Emphasis Type="Italic">arrow</Emphasis>) and trapped secretions in the sphenoid sinuses (<Emphasis Type="Italic">arrowheads</Emphasis>)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO13">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig13_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig14">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.14</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Orbital exenteration with cosmetic ectoprosthesis. The patient has a history of basal cell carcinoma involving the left face with orbital invasion and is status post orbital exenteration. Axial (<Emphasis Type="Bold">a</Emphasis>) CT image shows a custom-fit hyperattenuating prosthesis (<Emphasis Type="Italic">arrow</Emphasis>) that covers the left orbital exenteration cavity, which is lined by a skin graft. The 3D volume-rendered CT image (<Emphasis Type="Bold">b</Emphasis>) shows a satisfactory cosmetic result, although the artificial eyelids do not blink</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO14">
                <ImageObject Color="Color" FileRef="MediaObjects/307975_1_En_8_Fig14_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig15">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.15</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Exenteration with implant. The patient has a history of left choroidal melanoma with extrascleral extension, status post left orbital exenteration with augmentation of the cavity with a spherical silicone implant affixed to the lateral orbital rim, as shown on the axial T1-weighted MRI, in which the hypointense implant is covered by skin graft (<Emphasis Type="Italic">arrow</Emphasis>)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO15">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig15_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>Complications have been reported in over 20 % of exenterations in the setting of orbital oncology and include fistula formation, infection, flap necrosis, CSF leak, and tumor recurrence. Fistulas most commonly occur from the orbit to the ethmoid sinuses but can extend to other sites. On imaging, fistulas may appear as air-filled channels, which are best depicted on CT (Fig. <InternalRef RefID="Fig16">8.16</InternalRef>). Fistulas are sometimes associated with infection. Otherwise, infections appear as nonspecific fluid collections that can be difficult to distinguish from seromas or CSF leaks based on imaging alone. Tumor recurrence most commonly occurs at the margins of the reconstruction flap (Fig. <InternalRef RefID="Fig17">8.17</InternalRef>). It is also important to be vigilant for lymph node metastases, intracranial metastases, and perineural tumor spread, all of which can manifest after exenteration. CT with contrast is typically adequate for delineating lymph nodes, while MRI with contrast is more sensitive for depicting intracranial metastases. MRI with contrast is also particularly useful for depicting the presence of perineural tumor spread, which appears as excess thickening and enhancement of the involved nerve segments (Fig. <InternalRef RefID="Fig18">8.18</InternalRef>). The incidence and form of tumor recurrence are highly dependent on the tumor histology and staging. For example, squamous cell carcinomas and adenoid cystic carcinomas have a relative propensity for perineural spread. In addition, adenoid cystic carcinomas can metastasize to the dura and mimic meningiomas (Fig. <InternalRef RefID="Fig19">8.19</InternalRef>).
<Figure Category="Standard" Float="Yes" ID="Fig16">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.16</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Fistula. The patient underwent orbital exenteration with removal of a portion of the orbital roof and paranasal sinuses. Axial CT images (<Emphasis Type="Bold">a</Emphasis>–<Emphasis Type="Bold">d</Emphasis>) show an air-filled tract (<Emphasis Type="Italic">arrows</Emphasis>) that extends from the epidural space adjacent to an area of bony dehiscence to a skin defect along margins of the myocutaneous flap</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO16">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig16_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig17">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.17</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Local and regional tumor recurrence. The patient has a history of squamous cell carcinoma that involved the orbit, which was treated with orbital exenteration and myocutaneous flap reconstruction. Axial CT image (<Emphasis Type="Bold">a</Emphasis>) shows a heterogeneously enhancing mass (<Emphasis Type="Italic">arrows</Emphasis>) that occupies the exenteration bed, deep to the flap. In addition, the coronal CT image (<Emphasis Type="Bold">b</Emphasis>) shows metastatic lymphadenopathy (<Emphasis Type="Italic">arrowheads</Emphasis>)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO17">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig17_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig18">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.18</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Perineural tumor spread. The patient has a history of facial squamous cell carcinoma with invasion of the right orbit and is status post orbital exenteration. Axial post-contrast fat-suppressed T1-weighted MRI shows diffuse thickening and enhancement of the right trigeminal nerve with extension into the pons (<Emphasis Type="Italic">arrow</Emphasis>)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO18">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig18_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig19">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.19</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Intracranial metastases mimicking meningioma after orbital exenteration. The patient has a history of adenoid cystic carcinoma of the lacrimal gland. Axial post-contrast T1-weighted MRI shows a dural metastasis along the left temporal convexity (<Emphasis Type="Italic">arrow</Emphasis>). There is a myocutaneous flap within the left orbital exenteration cavity </SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO19">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig19_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/>
              </MediaObject>
            </Figure>
          </Para>
        </Section1>
        <Section1 ID="Sec5">
          <Heading>Optic Nerve Resection</Heading>
          <Para>Resection of the optic nerve along with optic nerve sheath meningiomas was first described by Cushing and Eisenhardt in 1938. En bloc resection of the tumor and involved optic nerve is sometimes performed for patients who have progressive growth of the tumor posteriorly that threatens to involve the optic chiasm or intracranial structures. The globe is typically left intact if it is not involved by the tumor, for cosmetic purposes and to avoid the difficulties associated with orbital implants. MRI is the modality of choice for the postoperative assessment of residual or recurrent optic nerve meningioma. In particular, it is important to evaluate for the presence of intracranial optic nerve meningioma, which can potentially spread to the contralateral side. Nevertheless, the surgery itself can produce a striking appearance on imaging, in which the globe is present, while both the optic nerve sheath and optic nerve are absent along variable lengths, and if the canalicular segment is removed, the optic canal fills with CSF (Fig. <InternalRef RefID="Fig20">8.20</InternalRef>).
<Figure Category="Standard" Float="Yes" ID="Fig20">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.20</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Optic nerve resection. The patient has a history of right optic nerve meningioma with complete loss of vision and intracranial extension. Preoperative axial (<Emphasis Type="Bold">a</Emphasis>) and coronal (<Emphasis Type="Bold">b</Emphasis>) post-contrast T1-weighted MR images show an enhancing, diffuse, plaque-like mass along the right optic nerve sheath (<Emphasis Type="Italic">arrows</Emphasis>). Postoperative coronal T2-weighted MR images (<Emphasis Type="Bold">c</Emphasis>–<Emphasis Type="Bold">f</Emphasis>) show that the right globe remains intact, but the right optic nerve and nerve sheath are absent. There was no evidence of recurrent tumor</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO20">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig20a_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig20b_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
        </Section1>
        <Section1 ID="Sec6">
          <Heading>Radiation Therapy</Heading>
          <Para>External beam radiation therapy (EBRT) is widely used for the treatment of a variety of orbital tumors. EBRT is delivered using photons or particles such as protons or neutrons via a linear accelerator. Stereotactic radiosurgery (SRS) typically involves a single fraction of radiation and has different subtypes including the gamma knife and proton irradiation. The gamma knife uses over 200 converging gamma-ray beams and is ideal for treatment of small- to medium-sized lesions. Proton beam therapy involves the delivery of high energy protons to the tumor. A dose of 50–70 Gy is typically given in 4–5 fractions. If the site of treatment is the globe, such as in the case of choroidal melanoma, small rings made of tantalum are first surgically sutured to the eye for localization of the tumor during the treatment (Fig. <InternalRef RefID="Fig21">8.21</InternalRef>). These rings are MRI compatible. Brachytherapy involves the surgical placement of a radioactive material onto the sclera directly adjacent to the tumor. Tumors of the bulbar conjunctiva, squamous carcinoma, and malignant melanoma can be treated with a radioactive plaque: strontium-90, ruthenium-106 (Ru-106), or iodine-125 (I-125), after excision. Alternatively, an I-125 interstitial implant can be used with shielding of the cornea and lens. Brachytherapy implants are usually left in place transiently and therefore are uncommonly encountered on imaging. However, if perioperative ultrasound is performed to evaluate for potential complications, the implants appear as linear hyperechogenicity along the surface of the globe (Fig. <InternalRef RefID="Fig22">8.22</InternalRef>).
<Figure Category="Standard" Float="Yes" ID="Fig21">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.21</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Tantalum rings. Axial (<Emphasis Type="Bold">a</Emphasis>) and coronal (<Emphasis Type="Bold">b</Emphasis>) CT images show several punctate hyperattenuating tantalum rings attached to the inferomedial aspect of the left globe</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO21">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig21_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig22">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.22</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Brachytherapy plaque. The patient has a history of choroidal melanoma. B-mode ultrasound (<Emphasis Type="Bold">a</Emphasis>) demonstrates the echogenic brachytherapy plaque positioned alongside the globe (<Emphasis Type="Italic">arrows</Emphasis>) and the intraocular tumor (<Emphasis Type="Italic">arrowhead</Emphasis>). Intraoperative photograph (<Emphasis Type="Bold">b</Emphasis>) of the brachytherapy plaque in situ (Courtesy of Arun Singh MD)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO22">
                <ImageObject Color="Color" FileRef="MediaObjects/307975_1_En_8_Fig22_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>Many side effects from radiation therapy delivered for treatment of orbital region tumor can be encountered on imaging, both in the early and late posttreatment periods and within or beyond the confines of the orbit. These include orbital fat atrophy, vasculopathy, optic neuropathy, osteoradionecrosis, and secondary neoplasms.</Para>
          <Para>Radiation-induced orbital fat atrophy can result in enophthalmos and reduced ocular motility. There can also be contractile fibrosis of the orbital connective tissues and extraocular muscles, which contributes to the symptoms. Diagnostic imaging can be used to assess the reduction in orbital volume (Fig. <InternalRef RefID="Fig23">8.23</InternalRef>).
<Figure Category="Standard" Float="Yes" ID="Fig23">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.23</CaptionNumber>
                <CaptionContent>
                  <SimplePara>The patient has a history of widespread metastatic breast cancer (non-scirrhous type) with left inferior and lateral rectus muscle orbital metastases treated with radiation. Axial T1-weighted (<Emphasis Type="Bold">a</Emphasis>) and coronal fat-suppressed T2-weighted (<Emphasis Type="Bold">b</Emphasis>) MR images show left enophthalmos due to diffusely reduced orbital fat content and asymmetric left extraocular muscle atrophy, mainly involving the inferior and lateral rectus muscles. There is also a heterogeneous appearance of the calvarial bone marrow, which reflects the presence of widespread bone metastases (Courtesy of Juan Small MD)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO23">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig23_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>Radiation-induced vasculopathy can present many years after radiation to the orbit and can manifest as transient ischemic attacks or strokes. CTA or MRA are useful for the evaluation of the associated cerebrovascular steno-occlusive disease. This complication can affect small vessels as well as large vessels, such as the internal carotid artery (Fig. <InternalRef RefID="Fig24">8.24</InternalRef>).
<Figure Category="Standard" Float="Yes" ID="Fig24">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.24</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Radiation-induced vasculopathy. The patient has a history of bilateral retinoblastoma during childhood, which was treated on the right side with radiation and orbital exenteration and on the left side with enucleation. The patient recently presented with right-sided facial pain. Axial (<Emphasis Type="Bold">a</Emphasis>) and MIP (<Emphasis Type="Bold">b</Emphasis>) time-of-flight MRA images show absence of flow-related enhancement within the right internal carotid artery (<Emphasis Type="Italic">arrows</Emphasis>)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO24">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig24_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>Radiation necrosis of the brain is not an uncommon phenomenon in patients with orbital region malignancies treated with external beam radiation. The anterior temporal pole and inferior frontal lobes are the most commonly affected sites. On CT, brain radiation necrosis appears as confluent areas of hypoattenuation, while on MRI there is confluent T2 hyperintensity that corresponds to vasogenic edema and areas of enhancement that may display a “Swiss cheese,” “cut pepper,” or “spreading wave front” pattern (Fig. <InternalRef RefID="Fig25">8.25</InternalRef>). However, the appearance of radiation necrosis can sometimes mimic brain metastases, and advanced imaging techniques can help differentiate tumor and radiation necrosis, such as MRI perfusion. For example, elevated perfusion suggests metastases over radiation necrosis. 18FDG-PET can also be useful, whereby radiation necrosis appears as hypometabolism, while metastases tend to display hypermetabolism, although this modality is limited by the underlying normal high cortical metabolism and low spatial resolution.
<Figure Category="Standard" Float="Yes" ID="Fig25">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.25</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Radiation necrosis of the brain. The patient has a history of a left orbital malignancy treated with radiation approximately 2 years earlier. Axial FLAIR (<Emphasis Type="Bold">a</Emphasis>), coronal fat-suppressed T2-weighted (<Emphasis Type="Bold">b</Emphasis>), and axial (<Emphasis Type="Bold">c</Emphasis>) and coronal (<Emphasis Type="Bold">d</Emphasis>) post-contrast fat-suppressed T1-weighted MR images show confluent vasogenic edema with areas of enhancement (<Emphasis Type="Italic">arrows</Emphasis>) that suggest a “soap bubble” appearance in the left frontal lobe, on the side of the orbital exenteration and within the field of the radiation</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO25">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig25_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>Radiation-induced optic neuropathy is a devastating late complication of radiotherapy to the anterior visual pathway that can result in acute and potentially irreversible visual loss. This complication may result from radiation necrosis of the anterior visual pathway and occurs on an average of 18 months after treatment, but the onset may range from 3 months to 9 years. Cumulative doses of radiation that exceed 50 Gy or single doses to the anterior visual pathway greater than 10 Gy usually precede radiation-induced optic neuropathy. MRI is the best modality for depicting radiation-induced optic neuropathy. On MRI, the affected optic nerve can display diffuse T2 hyperintensity, mild enhancement, and swelling (Fig. <InternalRef RefID="Fig26">8.26</InternalRef>).
<Figure Category="Standard" Float="Yes" ID="Fig26">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.26</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Radiation-induced optic neuropathy. Coronal T2-weighted (<Emphasis Type="Bold">a</Emphasis>) and post-contrast fat-suppressed T1-weighted (<Emphasis Type="Bold">b</Emphasis>) MR images show a swollen and enhancing right optic nerve (<Emphasis Type="Italic">arrows</Emphasis>) in a patient who underwent radiotherapy to the right orbit approximately 2 years before</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO26">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig26_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>Osteoradionecrosis is relatively uncommon in the region of the orbit compared to other sites in the head and neck. Nevertheless, this is an important complication that is difficult to treat and can be responsible for delayed socket healing. Osteoradionecrosis is defined as an area of exposed devitalized irradiated bone, with failure to heal during a period of at least 3 months, in the absence of local neoplastic disease. It is important to differentiate osteoradionecrosis from local recurrence of malignancy, bone metastasis, radiation-induced sarcoma, and infection. Both CT and MRI are effective and often complementary diagnostic modalities for the evaluation of osteoradionecrosis, which can appear as areas of irregular bone destruction and sclerosis (Fig. <InternalRef RefID="Fig27">8.27</InternalRef>). There may also be associated enhancement of the involved bone and surrounding soft tissues.
<Figure Category="Standard" Float="Yes" ID="Fig27">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.27</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Osteoradionecrosis. The patient underwent external beam radiation therapy and enucleation surgery for retinoblastoma and presented with a wound defect. Axial (<Emphasis Type="Bold">a</Emphasis>) and coronal (<Emphasis Type="Bold">b</Emphasis>) CT images show a soft tissue defect (<Emphasis Type="Italic">arrow</Emphasis>) overlying exposed bone, which displays mixed lucent and sclerotic appearance consistent with osteoradionecrosis</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO27">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig27_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>A variety of secondary tumors can arise from radiation therapy to the orbit, including meningiomas, leiomyosarcomas, fibrosarcomas, chondrosarcomas, and osteosarcomas. Osteosarcoma is the most common secondary malignant neoplasm in survivors of retinoblastoma treated with radiation and typically develops after a latency period of 5–10 years after doses in excess of 3,000 Gy. These tumors characteristically occur at the edge of the radiation field because the administered radiation in this location does not cause cell death but is sufficient to induce malignant transformation. CT is superior for depicting the presence of matrix mineralization, periosteal reaction, and cortical destruction, whereas MRI is better for delineating soft tissue and intracranial extension and for differentiating enhancing tumor from non-enhancing sinus secretions (Fig. <InternalRef RefID="Fig28">8.28</InternalRef>). Tumor matrix mineralization and aggressive bone destruction are strongly suggestive of osteosarcoma. Matrix mineralization and periosteal new bone formation favor a diagnosis of osteosarcoma over metastatic carcinoma, lymphoma, and myeloma; a destructive mass is generally not found in radiation osteitis. A less aggressive osteosarcoma may be radiologically indistinguishable from chondrosarcoma.
<Figure Category="Standard" Float="Yes" ID="Fig28">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.28</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Radiation-induced osteosarcoma. The patient has a history of retinoblastoma treated with enucleation and radiation many years prior. Axial (<Emphasis Type="Bold">a</Emphasis>) and coronal (<Emphasis Type="Bold">b</Emphasis>) CT images show a large mass involving the right maxilla and orbit containing both soft tissue and mineralized components (<Emphasis Type="Italic">arrows</Emphasis>). Postoperative findings reveal bilateral enucleations with a nonporous spherical orbital implant and ocular prosthesis on the left. Axial and coronal T2-weighted (<Emphasis Type="Bold">c</Emphasis>, <Emphasis Type="Bold">d</Emphasis>) and axial and coronal (<Emphasis Type="Bold">e</Emphasis>, <Emphasis Type="Bold">f)</Emphasis> post-contrast fat-suppressed T1-weighted MR images show a heterogeneously enhancing lobulated mass extending intracranially</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO28">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig28a_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig28b_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
        </Section1>
        <Section1 ID="Sec7">
          <Heading>Chemotherapy</Heading>
          <Para>Primary chemotherapy is indicated for selected cases of intraocular retinoblastoma, optic glioma, rhabdomyosarcoma and other malignant mesenchymal tumors, and metastases. Induction chemotherapy is also frequently administered to reduce the size of the tumor to facilitate other treatments, such as cryotherapy, laser photocoagulation, resection, and radiation. Finally, chemotherapy may be administered as an adjunct to radiation and surgery. There are many chemotherapy agents and regimens used in clinical practice and they are in constant evolution.</Para>
          <Para>The main role of imaging in patients receiving primary chemotherapy for orbital tumors is for evaluation of treatment response. Furthermore, treated lesions can show changes in signal characteristic on MRI. For example, regressing tumors may show decreased enhancement and increased diffusivity in echo-planar diffusion-weighted imaging (Fig. <InternalRef RefID="Fig29">8.29</InternalRef>). The increased diffusivity often observed in treated tumors is attributable to cell death and an increased proportion of water content. Potential pitfalls of diffusion-weighted imaging include the presence of calcifications and hemorrhage, which can affect ADC values. In addition, the orbital region is often affected by distortion from susceptibility effects at the air-tissue interfaces, and measurements made on very small lesions may be subject to the effects of partial volume averaging.
<Figure Category="Standard" Float="Yes" ID="Fig29">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.29</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Treatment response. Pretreatment axial T2-weighted (<Emphasis Type="Bold">a</Emphasis>) and post-contrast T1-weighted (<Emphasis Type="Bold">b</Emphasis>) images and ADC map (<Emphasis Type="Bold">c</Emphasis>) show a T2 hypointense, enhancing intraocular mass (<Emphasis Type="Italic">arrows</Emphasis>) with markedly reduced ADC. Following the administration of chemotherapy, the corresponding MR images (<Emphasis Type="Bold">d</Emphasis>–<Emphasis Type="Bold">f</Emphasis>) show interval decrease in size and enhancement of the tumor (<Emphasis Type="Italic">arrows</Emphasis>), as well as increased diffusivity (regions of interest are drawn over the tumor for reference)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO29">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig29a_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig29b_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>There are potential limitations of orbital imaging in these patients. For example, although visual deterioration may prompt an MRI of the orbits in the case of optic gliomas, the change in clinical status is not always accompanied by a discernable change in the MRI appearance of the optic glioma. Furthermore, some chemotherapy agents, such as ipilimumab, can induce a flare response that appears as a spurious increase in hypermetabolism on 18FDG-PET that can be misinterpreted as tumor progression. In addition to the possibility of local and regional tumor recurrence, it is important to monitor distant involvement. In the case of retinoblastoma, follow-up with brain MRI is routinely performed to assess for involvement of the suprasellar and/or pineal regions (Fig. <InternalRef RefID="Fig30">8.30</InternalRef>). Furthermore, these tumors can rarely have spine leptomeningeal drop metastases. MRI with contrast is the modality of choice for evaluating this phenomenon, since the lesions tend to avidly enhance.
<Figure Category="Standard" Float="Yes" ID="Fig30">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.30</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Trilateral retinoblastoma and drop metastases. The patient is status post chemotherapy for ocular retinoblastoma and subsequently developed a suprasellar mass and spine drop metastases. Axial (<Emphasis Type="Bold">a</Emphasis>) and sagittal (<Emphasis Type="Bold">b</Emphasis>) post-contrast T1-weighted MR images of the brain show an enhancing bulky suprasellar mass. Axial (<Emphasis Type="Bold">c</Emphasis>) and sagittal (<Emphasis Type="Bold">d</Emphasis>) post-contrast T1-weighted MR images of the spine show numerous enhancing nodules along the cauda equina (<Emphasis Type="Italic">arrows</Emphasis>)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO30">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig30_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
        </Section1>
        <Section1 ID="Sec8">
          <Heading>Management of the Orbit in Malignant Sinonasal Disease</Heading>
          <Para>Malignant ethmoid and maxillary sinus tumors may involve the orbit. The periorbita, which surrounds the orbital contents, generally provides a barrier against invading tumors from coming into direct contact with or infiltrating the orbital structures. In these cases, tumor resections often spare the orbital contents. The pressure exerted by such tumors may, however, result in globe distortion and compressive optic neuropathy. Tumors may occasionally penetrate the periorbita and invade the orbital soft tissues. Cross-sectional imaging plays a major role in posttreatment follow-up for identifying and characterizing residual or recurrent tumor in the orbit and its surroundings (Fig. <InternalRef RefID="Fig31">8.31</InternalRef>). Another postsurgical complication specific to the orbit that can be evaluated via CT and/or MRI is malposition of the globe, which can result from inadequate reconstruction of the orbital walls, extraorbital fluid collections, or hemorrhage (Figs. <InternalRef RefID="Fig32">8.32</InternalRef> and <InternalRef RefID="Fig33">8.33</InternalRef>).
<Figure Category="Standard" Float="Yes" ID="Fig31">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.31</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Recurrent sinonasal tumor involving the orbit. The patient has a history of sinonasal squamous cell carcinoma status post maxillectomy with orbit preservation and status post adjuvant radiation and chemotherapy. Coronal CT image shows tumor (<Emphasis Type="Italic">arrow</Emphasis>) that extends into the right intraconal space where it encases the inferior and lateral rectus muscles</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO31">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig31_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig32">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.32</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Enophthalmos following sinonasal melanoma resection. Preoperative axial (<Emphasis Type="Bold">a</Emphasis>) and coronal (<Emphasis Type="Bold">b</Emphasis>) CT images show right hyperglobus related to extension of the right maxillary sinus tumor into the extraconal orbit via a defect in the orbital floor. Postoperative axial (<Emphasis Type="Bold">c</Emphasis>) and coronal (<Emphasis Type="Bold">d</Emphasis>) CT images show interval tumor resection with new right enophthalmos associated with sagging of orbital contents through the persistent defect in the right orbital floor (<Emphasis Type="Italic">arrow</Emphasis>)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO32">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig32_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig33">
              <Caption Language="En">
                <CaptionNumber>Fig. 8.33</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Strabismus and globe compression after maxillectomy. The patient presented with ocular dysmotility following recent maxillectomy with myocutaneous flap and left orbital floor bone graft reconstruction. Sagittal (<Emphasis Type="Bold">a</Emphasis>) and coronal (<Emphasis Type="Bold">b</Emphasis>) CT images show compression of the globe due to superior displacement of an orbital floor bone graft (<Emphasis Type="Italic">arrows</Emphasis>) secondary to a swollen left maxillary sinus myocutaneous flap with hemorrhage</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO33">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_8_Fig33_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
        </Section1>
        <Section1 ID="Sec9">
          <Heading>Summary</Heading>
          <Para>
            <UnorderedList Mark="Bullet">
              <ItemContent>
                <Para>Diagnostic neuroimaging plays a key role in the posttreatment management of orbital region neoplasms.</Para>
              </ItemContent>
              <ItemContent>
                <Para>The main modalities used for posttreatment surveillance and metastatic workup are CT and MRI, with the exception of small intraocular tumors, which are best depicted on ultrasound. In some cases, 18FDG-PET can be useful for screening distant metastases.</Para>
              </ItemContent>
              <ItemContent>
                <Para>Diagnostic neuroimaging is also useful for evaluating many posttreatment complications, including hemorrhage, infection, radiation necrosis, secondary malignancies, vasculopathy, and graft and implant failures.</Para>
              </ItemContent>
              <ItemContent>
                <Para>Ultimately interpretation of posttreatment orbit imaging studies benefits from a thorough familiarity with the various types of treatment modalities and complications, availability of relevant clinical history, and a systematic approach towards reviewing the images.</Para>
              </ItemContent>
            </UnorderedList>
          </Para>
        </Section1>
      </Body>
      <BodyRef FileRef="978-3-662-44023-0_Chapter_8.pdf" OutputMedium="Online" PDFType="Typeset" TargetType="OnlinePDF"/>
      <ChapterBackmatter>
        <Bibliography ID="Bib1">
          <Heading>Further Reading</Heading>
          <Citation ID="CR1">
            <BibArticle>
              <BibAuthorName>
                <Initials>DH</Initials>
                <FamilyName>Abramson</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>RM</Initials>
                <FamilyName>Ellsworth</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>FD</Initials>
                <FamilyName>Kitchin</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>G</Initials>
                <FamilyName>Tung</FamilyName>
              </BibAuthorName>
              <Year>1984</Year>
              <ArticleTitle Language="En">Second Nonocular tumors in retinoblastoma survivors. Are they radiation induced?</ArticleTitle>
              <JournalTitle>Ophthalmology</JournalTitle>
              <VolumeID>91</VolumeID>
              <IssueID>11</IssueID>
              <FirstPage>1351</FirstPage>
              <LastPage>5</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DyaL2M%2Foslamsw%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>6595610</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1016/S0161-6420(84)34127-6</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Abramson DH, Ellsworth RM, Kitchin FD, Tung G. Second Nonocular tumors in retinoblastoma survivors. Are they radiation induced? Ophthalmology. 1984;91(11):1351–5.</BibUnstructured>
          </Citation>
          <Citation ID="CR2">
            <BibArticle>
              <BibAuthorName>
                <Initials>W</Initials>
                <FamilyName>Alberti</FamilyName>
              </BibAuthorName>
              <Year>1997</Year>
              <ArticleTitle Language="En">Acute and late side effects of radiotherapy for ocular disease: an overview</ArticleTitle>
              <JournalTitle>Front Radiat Ther Oncol</JournalTitle>
              <VolumeID>30</VolumeID>
              <FirstPage>281</FirstPage>
              <LastPage>6</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DyaK2szltVWgsQ%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>9205911</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Alberti W. Acute and late side effects of radiotherapy for ocular disease: an overview. Front Radiat Ther Oncol. 1997;30:281–6.</BibUnstructured>
          </Citation>
          <Citation ID="CR3">
            <BibArticle>
              <BibAuthorName>
                <Initials>L</Initials>
                <FamilyName>Alhilali</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>AR</Initials>
                <FamilyName>Reynods</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Fakhran</FamilyName>
              </BibAuthorName>
              <Year>2014</Year>
              <ArticleTitle Language="En">Osteoradionecrosis after radiation therapy for head and neck cancer: differentiation from recurrent disease with CT and PET/CT imaging</ArticleTitle>
              <JournalTitle>AJNR Am J Neuroradiol</JournalTitle>
              <VolumeID>35</VolumeID>
              <IssueID>7</IssueID>
              <FirstPage>1405</FirstPage>
              <LastPage>11</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DC%2BC2crjsFyrsg%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>24627451</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.3174/ajnr.A3879</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Alhilali L, Reynods AR, Fakhran S. Osteoradionecrosis after radiation therapy for head and neck cancer: differentiation from recurrent disease with CT and PET/CT imaging. AJNR Am J Neuroradiol. 2014;35(7):1405–11.</BibUnstructured>
          </Citation>
          <Citation ID="CR4">
            <BibArticle>
              <BibAuthorName>
                <Initials>MC</Initials>
                <FamilyName>Almond</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>AG</Initials>
                <FamilyName>Cheng</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>V</Initials>
                <FamilyName>Schiedler</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>BS</Initials>
                <FamilyName>Sires</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>SP</Initials>
                <FamilyName>Most</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Jian-Amadi</FamilyName>
              </BibAuthorName>
              <Year>2009</Year>
              <ArticleTitle Language="En">Decompression of the orbital apex: an alternate approach to surgical excision for radiographically benign orbital apex tumors</ArticleTitle>
              <JournalTitle>Arch Otolaryngol Head Neck Surg</JournalTitle>
              <VolumeID>135</VolumeID>
              <IssueID>10</IssueID>
              <FirstPage>1015</FirstPage>
              <LastPage>8</LastPage>
              <Occurrence Type="PID">
                <Handle>19841341</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1001/archoto.2009.147</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Almond MC, Cheng AG, Schiedler V, Sires BS, Most SP, Jian-Amadi A. Decompression of the orbital apex: an alternate approach to surgical excision for radiographically benign orbital apex tumors. Arch Otolaryngol Head Neck Surg. 2009;135(10):1015–8.</BibUnstructured>
          </Citation>
          <Citation ID="CR5">
            <BibArticle>
              <BibAuthorName>
                <Initials>JJ</Initials>
                <FamilyName>Augsburger</FamilyName>
              </BibAuthorName>
              <Year>2005</Year>
              <ArticleTitle Language="En">Diagnostic biopsy of selected Intraocular tumors</ArticleTitle>
              <JournalTitle>Am J Ophthalmol</JournalTitle>
              <VolumeID>140</VolumeID>
              <FirstPage>1094</FirstPage>
              <LastPage>5</LastPage>
              <Occurrence Type="PID">
                <Handle>16376657</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1016/j.ajo.2005.07.063</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Augsburger JJ. Diagnostic biopsy of selected Intraocular tumors. Am J Ophthalmol. 2005;140:1094–5.</BibUnstructured>
          </Citation>
          <Citation ID="CR6">
            <BibArticle>
              <BibAuthorName>
                <Initials>LW</Initials>
                <FamilyName>Brady</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>J</Initials>
                <FamilyName>Shields</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>J</Initials>
                <FamilyName>Augusburger</FamilyName>
              </BibAuthorName>
              <Etal/>
              <Year>1989</Year>
              <ArticleTitle Language="En">Complications from radiation therapy to the eye</ArticleTitle>
              <JournalTitle>Front Radiat Ther Oncol</JournalTitle>
              <VolumeID>23</VolumeID>
              <FirstPage>238</FirstPage>
              <LastPage>50</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DyaK3c7osFalug%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>2628189</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Brady LW, Shields J, Augusburger J, et al. Complications from radiation therapy to the eye. Front Radiat Ther Oncol. 1989;23:238–50.</BibUnstructured>
          </Citation>
          <Citation ID="CR7">
            <BibArticle>
              <BibAuthorName>
                <Initials>JR</Initials>
                <FamilyName>Cassady</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>RH</Initials>
                <FamilyName>Sagerman</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>P</Initials>
                <FamilyName>Tretter</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>RM</Initials>
                <FamilyName>Ellsworth</FamilyName>
              </BibAuthorName>
              <Year>1969</Year>
              <ArticleTitle Language="En">Radiation therapy in retinoblastoma. An analysis of 230 cases</ArticleTitle>
              <JournalTitle>Radiology</JournalTitle>
              <VolumeID>93</VolumeID>
              <IssueID>2</IssueID>
              <FirstPage>405</FirstPage>
              <LastPage>9</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DyaE3c%2FgtVyrsA%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>5822720</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1148/93.2.405</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Cassady JR, Sagerman RH, Tretter P, Ellsworth RM. Radiation therapy in retinoblastoma. An analysis of 230 cases. Radiology. 1969;93(2):405–9.</BibUnstructured>
          </Citation>
          <Citation ID="CR8">
            <BibArticle>
              <BibAuthorName>
                <Initials>W</Initials>
                <FamilyName>Chan</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>E</Initials>
                <FamilyName>Poh</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>D</Initials>
                <FamilyName>Bartholomeusz</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>D</Initials>
                <FamilyName>Selva</FamilyName>
              </BibAuthorName>
              <Year>2011</Year>
              <ArticleTitle Language="En">Novel use of positron emission tomography/computed tomography in the diagnosis of infected porous orbital implant</ArticleTitle>
              <JournalTitle>Clin Experiment Ophthalmol</JournalTitle>
              <VolumeID>39</VolumeID>
              <IssueID>7</IssueID>
              <FirstPage>704</FirstPage>
              <LastPage>5</LastPage>
              <Occurrence Type="PID">
                <Handle>22452688</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1111/j.1442-9071.2011.02535.x</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Chan W, Poh E, Bartholomeusz D, Selva D. Novel use of positron emission tomography/computed tomography in the diagnosis of infected porous orbital implant. Clin Experiment Ophthalmol. 2011;39(7):704–5.</BibUnstructured>
          </Citation>
          <Citation ID="CR9">
            <BibArticle>
              <BibAuthorName>
                <Initials>NJ</Initials>
                <FamilyName>Christmas</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>CD</Initials>
                <FamilyName>Gordon</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>TG</Initials>
                <FamilyName>Murray</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>D</Initials>
                <FamilyName>Tse</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>T</Initials>
                <FamilyName>Johnson</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Garonzik</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JM</Initials>
                <FamilyName>O'Brien</FamilyName>
              </BibAuthorName>
              <Year>1998</Year>
              <ArticleTitle Language="En">Intraorbital implants after enucleation and their complications, a 10 year review</ArticleTitle>
              <JournalTitle>Arch Ophthalmol</JournalTitle>
              <VolumeID>116</VolumeID>
              <FirstPage>1199</FirstPage>
              <LastPage>203</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DyaK1cvhvVCmsw%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>9747679</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1001/archopht.116.9.1199</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Christmas NJ, Gordon CD, Murray TG, Tse D, Johnson T, Garonzik S, O'Brien JM. Intraorbital implants after enucleation and their complications, a 10 year review. Arch Ophthalmol. 1998;116:1199–203.</BibUnstructured>
          </Citation>
          <Citation ID="CR10">
            <BibArticle>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Croce</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Moretti</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>L</Initials>
                <FamilyName>D’Agostino</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>P</Initials>
                <FamilyName>Zingariello</FamilyName>
              </BibAuthorName>
              <Year>2008</Year>
              <ArticleTitle Language="En">Orbital exenteration in elderly patients: personal experience</ArticleTitle>
              <JournalTitle>Acta Otorhinolaryngol Ital</JournalTitle>
              <VolumeID>28</VolumeID>
              <IssueID>4</IssueID>
              <FirstPage>193</FirstPage>
              <LastPage>9</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DC%2BD1cnnvVKlsA%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PMCID">
                <Handle>2644992</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>18939708</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Croce A, Moretti A, D’Agostino L, Zingariello P. Orbital exenteration in elderly patients: personal experience. Acta Otorhinolaryngol Ital. 2008;28(4):193–9.</BibUnstructured>
          </Citation>
          <Citation ID="CR11">
            <BibArticle>
              <BibAuthorName>
                <Initials>HV</Initials>
                <FamilyName>Danesh-Meyer</FamilyName>
              </BibAuthorName>
              <Year>2008</Year>
              <ArticleTitle Language="En">Radiation-induced optic neuropathy</ArticleTitle>
              <JournalTitle>J Clin Neurosci</JournalTitle>
              <VolumeID>15</VolumeID>
              <IssueID>2</IssueID>
              <FirstPage>95</FirstPage>
              <LastPage>100</LastPage>
              <Occurrence Type="PID">
                <Handle>18068989</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1016/j.jocn.2007.09.004</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Danesh-Meyer HV. Radiation-induced optic neuropathy. J Clin Neurosci. 2008;15(2):95–100.</BibUnstructured>
          </Citation>
          <Citation ID="CR12">
            <BibArticle>
              <BibAuthorName>
                <Initials>P</Initials>
                <FamilyName>Potter</FamilyName>
                <Particle>De</Particle>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>T</Initials>
                <FamilyName>Duprez</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>G</Initials>
                <FamilyName>Cosnard</FamilyName>
              </BibAuthorName>
              <Year>2000</Year>
              <ArticleTitle Language="En">Postcontrast magnetic resonance imaging assessment of porous polyethylene orbital implant (Medpor)</ArticleTitle>
              <JournalTitle>Ophthalmology</JournalTitle>
              <VolumeID>107</VolumeID>
              <IssueID>9</IssueID>
              <FirstPage>1656</FirstPage>
              <LastPage>60</LastPage>
              <Occurrence Type="PID">
                <Handle>10964823</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1016/S0161-6420(00)00249-9</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>De Potter P, Duprez T, Cosnard G. Postcontrast magnetic resonance imaging assessment of porous polyethylene orbital implant (Medpor). Ophthalmology. 2000;107(9):1656–60.</BibUnstructured>
          </Citation>
          <Citation ID="CR13">
            <BibArticle>
              <BibAuthorName>
                <Initials>CS</Initials>
                <FamilyName>Eddleman</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JK</Initials>
                <FamilyName>Liu</FamilyName>
              </BibAuthorName>
              <Year>2007</Year>
              <ArticleTitle Language="En">Optic nerve sheath meningioma: current diagnosis and treatment</ArticleTitle>
              <JournalTitle>Neurosurg Focus</JournalTitle>
              <VolumeID>23</VolumeID>
              <IssueID>5</IssueID>
              <FirstPage>E4</FirstPage>
              <Occurrence Type="PID">
                <Handle>18004966</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.3171/FOC-07/11/E4</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Eddleman CS, Liu JK. Optic nerve sheath meningioma: current diagnosis and treatment. Neurosurg Focus. 2007;23(5):E4.</BibUnstructured>
          </Citation>
          <Citation ID="CR14">
            <BibArticle>
              <BibAuthorName>
                <Initials>N</Initials>
                <FamilyName>Eide</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>L</Initials>
                <FamilyName>Walaas</FamilyName>
              </BibAuthorName>
              <Year>2009</Year>
              <ArticleTitle Language="En">Fine-needle aspiration biopsy and other biopsies in suspected intraocular malignant disease: a review</ArticleTitle>
              <JournalTitle>Acta Ophthalmologica</JournalTitle>
              <VolumeID>83</VolumeID>
              <FirstPage>588</FirstPage>
              <LastPage>601</LastPage>
              <Occurrence Type="DOI">
                <Handle>10.1111/j.1755-3768.2009.01637.x</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Eide N, Walaas L. Fine-needle aspiration biopsy and other biopsies in suspected intraocular malignant disease: a review. Acta Ophthalmologica. 2009;83:588–601.</BibUnstructured>
          </Citation>
          <Citation ID="CR15">
            <BibArticle>
              <BibAuthorName>
                <Initials>T</Initials>
                <FamilyName>El-Sawy</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>SJ</Initials>
                <FamilyName>Frank</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>E</Initials>
                <FamilyName>Hanna</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Sniegowski</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>SY</Initials>
                <FamilyName>Lai</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>QJ</Initials>
                <FamilyName>Nasser</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>J</Initials>
                <FamilyName>Myers</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>B</Initials>
                <FamilyName>Esmaeli</FamilyName>
              </BibAuthorName>
              <Year>2013</Year>
              <ArticleTitle Language="En">Multidisciplinary management of lacrimal sac/nasolacrimal duct carcinomas</ArticleTitle>
              <JournalTitle>Ophthal Plast Reconstr Surg</JournalTitle>
              <VolumeID>29</VolumeID>
              <IssueID>6</IssueID>
              <FirstPage>454</FirstPage>
              <LastPage>7</LastPage>
              <Occurrence Type="PID">
                <Handle>24195987</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1097/IOP.0b013e31829f3a73</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>El-Sawy T, Frank SJ, Hanna E, Sniegowski M, Lai SY, Nasser QJ, Myers J, Esmaeli B. Multidisciplinary management of lacrimal sac/nasolacrimal duct carcinomas. Ophthal Plast Reconstr Surg. 2013;29(6):454–7.</BibUnstructured>
          </Citation>
          <Citation ID="CR16">
            <BibArticle>
              <BibAuthorName>
                <Initials>PT</Initials>
                <FamilyName>Finger</FamilyName>
              </BibAuthorName>
              <Year>2009</Year>
              <ArticleTitle Language="En">Radiation therapy for orbital tumors: concepts, current use, and ophthalmic radiation side effects</ArticleTitle>
              <JournalTitle>Surv Ophthalmol</JournalTitle>
              <VolumeID>54</VolumeID>
              <IssueID>5</IssueID>
              <FirstPage>545</FirstPage>
              <LastPage>68</LastPage>
              <Occurrence Type="PID">
                <Handle>19682622</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1016/j.survophthal.2009.06.004</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Finger PT. Radiation therapy for orbital tumors: concepts, current use, and ophthalmic radiation side effects. Surv Ophthalmol. 2009;54(5):545–68.</BibUnstructured>
          </Citation>
          <Citation ID="CR17">
            <BibArticle>
              <BibAuthorName>
                <Initials>GF</Initials>
                <FamilyName>Graue</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>PT</Initials>
                <FamilyName>Finger</FamilyName>
              </BibAuthorName>
              <Year>2012</Year>
              <ArticleTitle Language="En">Physiologic positron emission tomography/CT imaging of an integrated orbital implant</ArticleTitle>
              <JournalTitle>Ophthal Plast Reconstr Surg</JournalTitle>
              <VolumeID>28</VolumeID>
              <IssueID>1</IssueID>
              <FirstPage>e4</FirstPage>
              <LastPage>6</LastPage>
              <Occurrence Type="PID">
                <Handle>21386739</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1097/IOP.0b013e31820d8716</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Graue GF, Finger PT. Physiologic positron emission tomography/CT imaging of an integrated orbital implant. Ophthal Plast Reconstr Surg. 2012;28(1):e4–6.</BibUnstructured>
          </Citation>
          <Citation ID="CR18">
            <BibArticle>
              <BibAuthorName>
                <Initials>G</Initials>
                <FamilyName>Hadad</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>L</Initials>
                <FamilyName>Bassagasteguy</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>RL</Initials>
                <FamilyName>Carrau</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JC</Initials>
                <FamilyName>Mataza</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Kassam</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>CH</Initials>
                <FamilyName>Snyderman</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Mintz</FamilyName>
              </BibAuthorName>
              <Year>2006</Year>
              <ArticleTitle Language="En">A novel reconstructive technique after endoscopic expanded endonasal approaches: vascular pedicle nasoseptal flap</ArticleTitle>
              <JournalTitle>Laryngoscope</JournalTitle>
              <VolumeID>116</VolumeID>
              <IssueID>10</IssueID>
              <FirstPage>1882</FirstPage>
              <LastPage>6</LastPage>
              <Occurrence Type="PID">
                <Handle>17003708</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1097/01.mlg.0000234933.37779.e4</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Hadad G, Bassagasteguy L, Carrau RL, Mataza JC, Kassam A, Snyderman CH, Mintz A. A novel reconstructive technique after endoscopic expanded endonasal approaches: vascular pedicle nasoseptal flap. Laryngoscope. 2006;116(10):1882–6.</BibUnstructured>
          </Citation>
          <Citation ID="CR19">
            <BibArticle>
              <BibAuthorName>
                <Initials>HA</Initials>
                <FamilyName>Helms</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>HE</Initials>
                <FamilyName>Zeiger</FamilyName>
                <Suffix>Jr</Suffix>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Callahan</FamilyName>
              </BibAuthorName>
              <Year>1987</Year>
              <ArticleTitle Language="En">Complications following enucleation and Implantation of Multiple Glass Spheres in the Orbit</ArticleTitle>
              <JournalTitle>Ophthal Plast Reconst Surg</JournalTitle>
              <VolumeID>3</VolumeID>
              <FirstPage>87</FirstPage>
              <LastPage>9</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DyaK3M7lvFartg%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1097/00002341-198703020-00006</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Helms HA, Zeiger Jr HE, Callahan A. Complications following enucleation and Implantation of Multiple Glass Spheres in the Orbit. Ophthal Plast Reconst Surg. 1987;3:87–9.</BibUnstructured>
          </Citation>
          <Citation ID="CR20">
            <BibArticle>
              <BibAuthorName>
                <Initials>JI</Initials>
                <FamilyName>Hui</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>TG</Initials>
                <FamilyName>Murray</FamilyName>
              </BibAuthorName>
              <Year>2006</Year>
              <ArticleTitle Language="En">Radioactive plaque therapy</ArticleTitle>
              <JournalTitle>Int Ophthalmol Clin</JournalTitle>
              <VolumeID>46</VolumeID>
              <IssueID>1</IssueID>
              <FirstPage>51</FirstPage>
              <LastPage>68</LastPage>
              <Occurrence Type="PID">
                <Handle>16365555</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1097/01.iio.0000195860.94429.03</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Hui JI, Murray TG. Radioactive plaque therapy. Int Ophthalmol Clin. 2006;46(1):51–68.</BibUnstructured>
          </Citation>
          <Citation ID="CR21">
            <BibArticle>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Jamison</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>ME</Initials>
                <FamilyName>Gregory</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>DA</Initials>
                <FamilyName>Lyall</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>EG</Initials>
                <FamilyName>Kemp</FamilyName>
              </BibAuthorName>
              <Year>2013</Year>
              <ArticleTitle Language="En">Visual outcomes following orbital biopsy</ArticleTitle>
              <JournalTitle>Orbit</JournalTitle>
              <VolumeID>32</VolumeID>
              <IssueID>5</IssueID>
              <FirstPage>304</FirstPage>
              <LastPage>8</LastPage>
              <Occurrence Type="PID">
                <Handle>23895509</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.3109/01676830.2013.814688</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Jamison A, Gregory ME, Lyall DA, Kemp EG. Visual outcomes following orbital biopsy. Orbit. 2013;32(5):304–8.</BibUnstructured>
          </Citation>
          <Citation ID="CR22">
            <BibArticle>
              <BibAuthorName>
                <Initials>JW</Initials>
                <FamilyName>Kim</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>V</Initials>
                <FamilyName>Kathpalia</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>IJ</Initials>
                <FamilyName>Dunkel</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>RK</Initials>
                <FamilyName>Wong</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>E</Initials>
                <FamilyName>Riedel</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>DH</Initials>
                <FamilyName>Abramson</FamilyName>
              </BibAuthorName>
              <Year>2009</Year>
              <ArticleTitle Language="En">Orbital recurrence of retinoblastoma following enucleation</ArticleTitle>
              <JournalTitle>Br J Ophthalmol</JournalTitle>
              <VolumeID>93</VolumeID>
              <IssueID>4</IssueID>
              <FirstPage>463</FirstPage>
              <LastPage>7</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DC%2BD1M3jt1Smtw%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>18757474</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1136/bjo.2008.138453</Handle>
              </Occurrence>
              <BibComments>Epub 2008 Aug 29</BibComments>
            </BibArticle>
            <BibUnstructured>Kim JW, Kathpalia V, Dunkel IJ, Wong RK, Riedel E, Abramson DH. Orbital recurrence of retinoblastoma following enucleation. Br J Ophthalmol. 2009;93(4):463–7. Epub 2008 Aug 29.</BibUnstructured>
          </Citation>
          <Citation ID="CR23">
            <BibArticle>
              <BibAuthorName>
                <Initials>JC</Initials>
                <FamilyName>Lemon</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Kiat-amnuay</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>L</Initials>
                <FamilyName>Gettleman</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JW</Initials>
                <FamilyName>Martin</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>MS</Initials>
                <FamilyName>Chambers</FamilyName>
              </BibAuthorName>
              <Year>2005</Year>
              <ArticleTitle Language="En">Facial prosthetic rehabilitation: preprosthetic surgical techniques and biomaterials</ArticleTitle>
              <JournalTitle>Curr Opin Oto laryngol Head Neck Surg</JournalTitle>
              <VolumeID>13</VolumeID>
              <IssueID>4</IssueID>
              <FirstPage>255</FirstPage>
              <LastPage>62</LastPage>
              <Occurrence Type="DOI">
                <Handle>10.1097/01.moo.0000172805.48758.0c</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Lemon JC, Kiat-amnuay S, Gettleman L, Martin JW, Chambers MS. Facial prosthetic rehabilitation: preprosthetic surgical techniques and biomaterials. Curr Opin Oto laryngol Head Neck Surg. 2005;13(4):255–62.</BibUnstructured>
          </Citation>
          <Citation ID="CR24">
            <BibArticle>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Lessell</FamilyName>
              </BibAuthorName>
              <Year>2004</Year>
              <ArticleTitle Language="En">Friendly fire: neurogenic visual loss from radiation therapy</ArticleTitle>
              <JournalTitle>J Neuroophthalmol</JournalTitle>
              <VolumeID>24</VolumeID>
              <IssueID>3</IssueID>
              <FirstPage>243</FirstPage>
              <LastPage>50</LastPage>
              <Occurrence Type="PID">
                <Handle>15348995</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1097/00041327-200409000-00014</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Lessell S. Friendly fire: neurogenic visual loss from radiation therapy. J Neuroophthalmol. 2004;24(3):243–50.</BibUnstructured>
          </Citation>
          <Citation ID="CR25">
            <BibArticle>
              <BibAuthorName>
                <Initials>JK</Initials>
                <FamilyName>Liu</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Forman</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>CR</Initials>
                <FamilyName>Moorthy</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>DL</Initials>
                <FamilyName>Benzil</FamilyName>
              </BibAuthorName>
              <Year>2003</Year>
              <ArticleTitle Language="En">Update on treatment modalities for optic nerve sheath meningiomas</ArticleTitle>
              <JournalTitle>Neurosurg Focus</JournalTitle>
              <VolumeID>14</VolumeID>
              <IssueID>5</IssueID>
              <FirstPage>e7</FirstPage>
<Occurrence Type="DOI">
<Handle>10.3171/foc.2003.14.5.8</Handle>
</Occurrence>
            </BibArticle>
            <BibUnstructured>Liu JK, Forman S, Moorthy CR, Benzil DL. Update on treatment modalities for optic nerve sheath meningiomas. Neurosurg Focus. 2003;14(5):e7.</BibUnstructured>
          </Citation>
          <Citation ID="CR26">
            <BibArticle>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Locatelli</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>G</Initials>
                <FamilyName>Carrabba</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>C</Initials>
                <FamilyName>Guastella</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>SM</Initials>
                <FamilyName>Gaini</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>D</Initials>
                <FamilyName>Spagnoli</FamilyName>
              </BibAuthorName>
              <Year>2011</Year>
              <ArticleTitle Language="En">Endoscopic endonasal removal of a cavernous hemangioma of the orbital apex</ArticleTitle>
              <JournalTitle>Surg Neurol Int</JournalTitle>
              <VolumeID>2</VolumeID>
              <FirstPage>58</FirstPage>
              <Occurrence Type="PMCID">
                <Handle>3114373</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>21697974</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.4103/2152-7806.80123</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Locatelli M, Carrabba G, Guastella C, Gaini SM, Spagnoli D. Endoscopic endonasal removal of a cavernous hemangioma of the orbital apex. Surg Neurol Int. 2011;2:58.</BibUnstructured>
          </Citation>
          <Citation ID="CR27">
            <BibArticle>
              <BibAuthorName>
                <Initials>F</Initials>
                <FamilyName>López</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>C</Initials>
                <FamilyName>Suárez</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Carnero</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>C</Initials>
                <FamilyName>Martín</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>D</Initials>
                <FamilyName>Camporro</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JL</Initials>
                <FamilyName>Llorente</FamilyName>
              </BibAuthorName>
              <Year>2013</Year>
              <ArticleTitle Language="En">Free flaps in orbital exenteration: a safe and effective method for reconstruction</ArticleTitle>
              <JournalTitle>Eur Arch Otorhinolaryngol</JournalTitle>
              <VolumeID>270</VolumeID>
              <IssueID>6</IssueID>
              <FirstPage>1947</FirstPage>
              <LastPage>52</LastPage>
              <Occurrence Type="PID">
                <Handle>23229643</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1007/s00405-012-2308-9</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>López F, Suárez C, Carnero S, Martín C, Camporro D, Llorente JL. Free flaps in orbital exenteration: a safe and effective method for reconstruction. Eur Arch Otorhinolaryngol. 2013;270(6):1947–52.</BibUnstructured>
          </Citation>
          <Citation ID="CR28">
            <BibUnstructured>Makimoto Y, Yamamoto S, Takano H, Motoori K, Ueda T, Kazama T, Kaneoya K, Shimofusa R, Uno T, Ito H, Hanazawa T, Okamoto Y, Hayasaki K. Imaging findings of radiation-induced sarcoma of the head and neck. Br J Radiol. 2007;80(958):790–7. doi: <ExternalRef><RefSource>10.1259/bjr/20938070</RefSource><RefTarget TargetType="DOI" Address="10.1259/bjr/20938070"/></ExternalRef>.</BibUnstructured>
          </Citation>
          <Citation ID="CR29">
            <BibArticle>
              <BibAuthorName>
                <Initials>NS</Initials>
                <FamilyName>Margalit</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JB</Initials>
                <FamilyName>Lesser</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>J</Initials>
                <FamilyName>Moche</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>C</Initials>
                <FamilyName>Sen</FamilyName>
              </BibAuthorName>
              <Year>2003</Year>
              <ArticleTitle Language="En">Meningiomas involving the optic nerve: technical aspects and outcomes for a series of 50 patients</ArticleTitle>
              <JournalTitle>Neurosurgery</JournalTitle>
              <VolumeID>53</VolumeID>
              <IssueID>3</IssueID>
              <FirstPage>523</FirstPage>
              <LastPage>32</LastPage>
              <Occurrence Type="PID">
                <Handle>12943569</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1227/01.NEU.0000079506.75164.F4</Handle>
              </Occurrence>
              <BibComments>discussion 532–3</BibComments>
            </BibArticle>
            <BibUnstructured>Margalit NS, Lesser JB, Moche J, Sen C. Meningiomas involving the optic nerve: technical aspects and outcomes for a series of 50 patients. Neurosurgery. 2003;53(3):523–32; discussion 532–3.</BibUnstructured>
          </Citation>
          <Citation ID="CR30">
            <BibArticle>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Menderes</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Yilmaz</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>H</Initials>
                <FamilyName>Vayvada</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>C</Initials>
                <FamilyName>Demirdover</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Barutçu</FamilyName>
              </BibAuthorName>
              <Year>2002</Year>
              <ArticleTitle Language="En">Reverse temporalis muscle flap for the reconstruction of orbital exenteration defects</ArticleTitle>
              <JournalTitle>Ann Plast Surg</JournalTitle>
              <VolumeID>48</VolumeID>
              <IssueID>5</IssueID>
              <FirstPage>521</FirstPage>
              <LastPage>6</LastPage>
              <Occurrence Type="PID">
                <Handle>11981194</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1097/00000637-200205000-00013</Handle>
              </Occurrence>
              <BibComments>discussion 526–7</BibComments>
            </BibArticle>
            <BibUnstructured>Menderes A, Yilmaz M, Vayvada H, Demirdover C, Barutçu A. Reverse temporalis muscle flap for the reconstruction of orbital exenteration defects. Ann Plast Surg. 2002;48(5):521–6; discussion 526–7.</BibUnstructured>
          </Citation>
          <Citation ID="CR31">
            <BibArticle>
              <BibAuthorName>
                <Initials>T</Initials>
                <FamilyName>Morioka</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>T</Initials>
                <FamilyName>Matsushima</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>K</Initials>
                <FamilyName>Ikezaki</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Nagata</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Ohta</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>K</Initials>
                <FamilyName>Hasuo</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Fukui</FamilyName>
              </BibAuthorName>
              <Year>1993</Year>
              <ArticleTitle Language="En">Intracranial adenoid cystic carcinoma mimicking meningioma: report of two cases</ArticleTitle>
              <JournalTitle>Neuroradiology</JournalTitle>
              <VolumeID>35</VolumeID>
              <IssueID>6</IssueID>
              <FirstPage>462</FirstPage>
              <LastPage>5</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DyaK3szptVOhtw%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>8397344</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1007/BF00602833</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Morioka T, Matsushima T, Ikezaki K, Nagata S, Ohta M, Hasuo K, Fukui M. Intracranial adenoid cystic carcinoma mimicking meningioma: report of two cases. Neuroradiology. 1993;35(6):462–5.</BibUnstructured>
          </Citation>
          <Citation ID="CR32">
            <BibArticle>
              <BibAuthorName>
                <Initials>ME</Initials>
                <FamilyName>Mullins</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>GD</Initials>
                <FamilyName>Barest</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>PW</Initials>
                <FamilyName>Schaefer</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>FH</Initials>
                <FamilyName>Hochberg</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>RG</Initials>
                <FamilyName>Gonzalez</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>MH</Initials>
                <FamilyName>Lev</FamilyName>
              </BibAuthorName>
              <Year>2005</Year>
              <ArticleTitle Language="En">Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis</ArticleTitle>
              <JournalTitle>AJNR Am J Neuroradiol</JournalTitle>
              <VolumeID>26</VolumeID>
              <IssueID>8</IssueID>
              <FirstPage>1967</FirstPage>
              <LastPage>72</LastPage>
              <Occurrence Type="PID">
                <Handle>16155144</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Mullins ME, Barest GD, Schaefer PW, Hochberg FH, Gonzalez RG, Lev MH. Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis. AJNR Am J Neuroradiol. 2005;26(8):1967–72.</BibUnstructured>
          </Citation>
          <Citation ID="CR33">
            <BibArticle>
              <BibAuthorName>
                <Initials>RS</Initials>
                <FamilyName>Nassab</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>SS</Initials>
                <FamilyName>Thomas</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>D</Initials>
                <FamilyName>Murray</FamilyName>
              </BibAuthorName>
              <Year>2007</Year>
              <ArticleTitle Language="En">Orbital exenteration for advanced periorbital skin cancers: 20 years experience</ArticleTitle>
              <JournalTitle>J Plast Reconstr Aesthet Surg</JournalTitle>
              <VolumeID>60</VolumeID>
              <IssueID>10</IssueID>
              <FirstPage>1103</FirstPage>
              <LastPage>9</LastPage>
              <Occurrence Type="PID">
                <Handle>17434350</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1016/j.bjps.2007.02.012</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Nassab RS, Thomas SS, Murray D. Orbital exenteration for advanced periorbital skin cancers: 20 years experience. J Plast Reconstr Aesthet Surg. 2007;60(10):1103–9.</BibUnstructured>
          </Citation>
          <Citation ID="CR34">
            <BibArticle>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Nishino</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JP</Initials>
                <FamilyName>Jagannathan</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>NH</Initials>
                <FamilyName>Ramaiya</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>AD</Initials>
                <FamilyName>Abbeele</FamilyName>
                <Particle>Van den</Particle>
              </BibAuthorName>
              <Year>2010</Year>
              <ArticleTitle Language="En">Revised RECIST guideline version 1.1: what oncologists want to know and what radiologists need to know</ArticleTitle>
              <JournalTitle>AJR Am J Roentgenol</JournalTitle>
              <VolumeID>195</VolumeID>
              <IssueID>2</IssueID>
              <FirstPage>281</FirstPage>
              <LastPage>9</LastPage>
              <Occurrence Type="PID">
                <Handle>20651182</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.2214/AJR.09.4110</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Nishino M, Jagannathan JP, Ramaiya NH, Van den Abbeele AD. Revised RECIST guideline version 1.1: what oncologists want to know and what radiologists need to know. AJR Am J Roentgenol. 2010;195(2):281–9.</BibUnstructured>
          </Citation>
          <Citation ID="CR35">
            <BibArticle>
              <BibAuthorName>
                <Initials>C</Initials>
                <FamilyName>Offiah</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>E</Initials>
                <FamilyName>Hall</FamilyName>
              </BibAuthorName>
              <Year>2011</Year>
              <ArticleTitle Language="En">Post-treatment imaging appearances in head and neck cancer patients</ArticleTitle>
              <JournalTitle>Clin Radiol</JournalTitle>
              <VolumeID>66</VolumeID>
              <IssueID>1</IssueID>
              <FirstPage>13</FirstPage>
              <LastPage>24</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DC%2BC3M%2FktVSksQ%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>21147294</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1016/j.crad.2010.09.004</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Offiah C, Hall E. Post-treatment imaging appearances in head and neck cancer patients. Clin Radiol. 2011;66(1):13–24.</BibUnstructured>
          </Citation>
          <Citation ID="CR36">
            <BibArticle>
              <BibAuthorName>
                <Initials>H</Initials>
                <FamilyName>Ozdemir</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>C</Initials>
                <FamilyName>Yücel</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>C</Initials>
                <FamilyName>Aytekin</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>B</Initials>
                <FamilyName>Onal</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Ataman</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>Y</Initials>
                <FamilyName>Ozsunar</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Işik</FamilyName>
              </BibAuthorName>
              <Year>1997</Year>
              <ArticleTitle Language="En">Intraocular tumors. The value of spectral and color Doppler sonography</ArticleTitle>
              <JournalTitle>Clin Imaging</JournalTitle>
              <VolumeID>21</VolumeID>
              <IssueID>2</IssueID>
              <FirstPage>77</FirstPage>
              <LastPage>81</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DyaK2s3kvFCqtw%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>9095381</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1016/0899-7071(95)00094-1</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Ozdemir H, Yücel C, Aytekin C, Onal B, Ataman A, Ozsunar Y, Işik S. Intraocular tumors. The value of spectral and color Doppler sonography. Clin Imaging. 1997;21(2):77–81.</BibUnstructured>
          </Citation>
          <Citation ID="CR37">
            <BibArticle>
              <BibAuthorName>
                <Initials>GD</Initials>
                <FamilyName>Padula</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>B</Initials>
                <FamilyName>McCormick</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>DH</Initials>
                <FamilyName>Abramson</FamilyName>
              </BibAuthorName>
              <Year>2002</Year>
              <ArticleTitle Language="En">Brain necrosis after enucleation, external beam cobalt radiotherapy, and systemic chemotherapy for retinoblastoma</ArticleTitle>
              <JournalTitle>Arch Ophthalmol</JournalTitle>
              <VolumeID>120</VolumeID>
              <IssueID>1</IssueID>
              <FirstPage>98</FirstPage>
              <LastPage>9</LastPage>
              <Occurrence Type="PID">
                <Handle>11786070</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1001/archopht.120.1.98</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Padula GD, McCormick B, Abramson DH. Brain necrosis after enucleation, external beam cobalt radiotherapy, and systemic chemotherapy for retinoblastoma. Arch Ophthalmol. 2002;120(1):98–9.</BibUnstructured>
          </Citation>
          <Citation ID="CR38">
            <BibArticle>
              <BibAuthorName>
                <Initials>PR</Initials>
                <FamilyName>Pereira</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>AN</Initials>
                <FamilyName>Odashiro</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>LA</Initials>
                <FamilyName>Lim</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>C</Initials>
                <FamilyName>Miyamoto</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>PL</Initials>
                <FamilyName>Blanco</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Odashiro</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Maloney</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>DF</Initials>
                <FamilyName>Souza</FamilyName>
                <Particle>De</Particle>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>MN</Initials>
                <FamilyName>Burnier</FamilyName>
                <Suffix>Jr</Suffix>
              </BibAuthorName>
              <Year>2013</Year>
              <ArticleTitle Language="En">Current and emerging treatment options for uveal melanoma</ArticleTitle>
              <JournalTitle>Clin Ophthalmol</JournalTitle>
              <VolumeID>7</VolumeID>
              <FirstPage>1669</FirstPage>
              <LastPage>82</LastPage>
              <Occurrence Type="PMCID">
                <Handle>3755706</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>24003303</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.2147/OPTH.S28863</Handle>
              </Occurrence>
              <BibComments>Epub 2013 Aug 22</BibComments>
            </BibArticle>
            <BibUnstructured>Pereira PR, Odashiro AN, Lim LA, Miyamoto C, Blanco PL, Odashiro M, Maloney S, De Souza DF, Burnier Jr MN. Current and emerging treatment options for uveal melanoma. Clin Ophthalmol. 2013;7:1669–82. Epub 2013 Aug 22.</BibUnstructured>
          </Citation>
          <Citation ID="CR39">
            <BibArticle>
              <BibAuthorName>
                <Initials>NM</Initials>
                <FamilyName>Peter</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>R</Initials>
                <FamilyName>Laitt</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>B</Initials>
                <FamilyName>Leatherbarrow</FamilyName>
              </BibAuthorName>
              <Year>2014</Year>
              <ArticleTitle Language="En">Osteoradionecrosis of the exenterated orbit</ArticleTitle>
              <JournalTitle>Orbit</JournalTitle>
              <VolumeID>33</VolumeID>
              <IssueID>3</IssueID>
              <FirstPage>220</FirstPage>
              <LastPage>2</LastPage>
              <Occurrence Type="PID">
                <Handle>24660959</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.3109/01676830.2014.884604</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Peter NM, Laitt R, Leatherbarrow B. Osteoradionecrosis of the exenterated orbit. Orbit. 2014;33(3):220–2.</BibUnstructured>
          </Citation>
          <Citation ID="CR40">
            <BibArticle>
              <BibAuthorName>
                <Initials>CD</Initials>
                <FamilyName>Pinheiro-Neto</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>CH</Initials>
                <FamilyName>Snyderman</FamilyName>
              </BibAuthorName>
              <Year>2013</Year>
              <ArticleTitle Language="En">Nasoseptal flap</ArticleTitle>
              <JournalTitle>Adv Oto rhino laryngol</JournalTitle>
              <VolumeID>74</VolumeID>
              <FirstPage>42</FirstPage>
              <LastPage>55</LastPage>
              <Occurrence Type="DOI">
                <Handle>10.1159/000342271</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Pinheiro-Neto CD, Snyderman CH. Nasoseptal flap. Adv Oto rhino laryngol. 2013;74:42–55.</BibUnstructured>
          </Citation>
          <Citation ID="CR41">
            <BibArticle>
              <BibAuthorName>
                <Initials>PD</Initials>
                <FamilyName>Potter</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>CL</Initials>
                <FamilyName>Shields</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JA</Initials>
                <FamilyName>Shields</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>AE</Initials>
                <FamilyName>Flanders</FamilyName>
              </BibAuthorName>
              <Year>1996</Year>
              <ArticleTitle Language="En">The role of magnetic resonance imaging in children with intraocular tumors and simulating lesions</ArticleTitle>
              <JournalTitle>Ophthalmology</JournalTitle>
              <VolumeID>103</VolumeID>
              <IssueID>11</IssueID>
              <FirstPage>1774</FirstPage>
              <LastPage>83</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DyaK2s%2FpvVehug%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>8942869</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1016/S0161-6420(96)30428-4</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Potter PD, Shields CL, Shields JA, Flanders AE. The role of magnetic resonance imaging in children with intraocular tumors and simulating lesions. Ophthalmology. 1996;103(11):1774–83.</BibUnstructured>
          </Citation>
          <Citation ID="CR42">
            <BibArticle>
              <BibAuthorName>
                <Initials>JM</Initials>
                <FamilyName>Provenzale</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Gururangan</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>G</Initials>
                <FamilyName>Klintworth</FamilyName>
              </BibAuthorName>
              <Year>2004</Year>
              <ArticleTitle Language="En">Trilateral retinoblastoma: clinical and radiologic progression</ArticleTitle>
              <JournalTitle>AJR Am J Roentgenol</JournalTitle>
              <VolumeID>183</VolumeID>
              <IssueID>2</IssueID>
              <FirstPage>505</FirstPage>
              <LastPage>11</LastPage>
              <Occurrence Type="PID">
                <Handle>15269048</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.2214/ajr.183.2.1830505</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Provenzale JM, Gururangan S, Klintworth G. Trilateral retinoblastoma: clinical and radiologic progression. AJR Am J Roentgenol. 2004;183(2):505–11.</BibUnstructured>
          </Citation>
          <Citation ID="CR43">
            <BibArticle>
              <BibAuthorName>
                <Initials>I</Initials>
                <FamilyName>Rahman</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>AE</Initials>
                <FamilyName>Cook</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>B</Initials>
                <FamilyName>Leatherbarrow</FamilyName>
              </BibAuthorName>
              <Year>2005</Year>
              <ArticleTitle Language="En">Orbital exenteration: a 13 year Manchester experience</ArticleTitle>
              <JournalTitle>Br J Ophthalmol</JournalTitle>
              <VolumeID>89</VolumeID>
              <FirstPage>1335</FirstPage>
              <LastPage>40</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DC%2BD2Mvps1Oiuw%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PMCID">
                <Handle>1772872</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>16170127</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1136/bjo.2004.062471</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Rahman I, Cook AE, Leatherbarrow B. Orbital exenteration: a 13 year Manchester experience. Br J Ophthalmol. 2005;89:1335–40.</BibUnstructured>
          </Citation>
          <Citation ID="CR44">
            <BibArticle>
              <BibAuthorName>
                <Initials>HD</Initials>
                <FamilyName>Remulla</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>PA</Initials>
                <FamilyName>Rubin</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JW</Initials>
                <FamilyName>Shore</FamilyName>
              </BibAuthorName>
              <Etal/>
              <Year>1995</Year>
              <ArticleTitle Language="En">Complications of Porous Spherical Orbital Implants</ArticleTitle>
              <JournalTitle>Ophthalmology</JournalTitle>
              <VolumeID>102</VolumeID>
              <FirstPage>586</FirstPage>
              <LastPage>93</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DyaK2M3ktFSktQ%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>7536909</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1016/S0161-6420(95)30991-8</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Remulla HD, Rubin PA, Shore JW, et al. Complications of Porous Spherical Orbital Implants. Ophthalmology. 1995;102:586–93.</BibUnstructured>
          </Citation>
          <Citation ID="CR45">
            <BibArticle>
              <BibAuthorName>
                <Initials>P</Initials>
                <FamilyName>Rousseau</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>F</Initials>
                <FamilyName>Flamant</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>E</Initials>
                <FamilyName>Quintana</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>PA</Initials>
                <FamilyName>Voute</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JC</Initials>
                <FamilyName>Gentet</FamilyName>
              </BibAuthorName>
              <Year>1994</Year>
              <ArticleTitle Language="En">Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit: results of the International Society of Pediatric Oncology MMT 84 Study</ArticleTitle>
              <JournalTitle>J Clin Oncol</JournalTitle>
              <VolumeID>12</VolumeID>
              <IssueID>3</IssueID>
              <FirstPage>516</FirstPage>
              <LastPage>21</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DyaK2c7msFKrtw%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>7509854</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Rousseau P, Flamant F, Quintana E, Voute PA, Gentet JC. Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit: results of the International Society of Pediatric Oncology MMT 84 Study. J Clin Oncol. 1994;12(3):516–21.</BibUnstructured>
          </Citation>
          <Citation ID="CR46">
            <BibArticle>
              <BibAuthorName>
                <Initials>N</Initials>
                <FamilyName>Saito</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>RN</Initials>
                <FamilyName>Nadgir</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Nakahira</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Takahashi</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Uchino</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>F</Initials>
                <FamilyName>Kimura</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>MT</Initials>
                <FamilyName>Truong</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>O</Initials>
                <FamilyName>Sakai</FamilyName>
              </BibAuthorName>
              <Year>2012</Year>
              <ArticleTitle Language="En">Posttreatment CT and MR imaging in head and neck cancer: what the radiologist needs to know</ArticleTitle>
              <JournalTitle>Radiographics</JournalTitle>
              <VolumeID>32</VolumeID>
              <IssueID>5</IssueID>
              <FirstPage>1261</FirstPage>
              <LastPage>82</LastPage>
              <Occurrence Type="PID">
                <Handle>22977017</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1148/rg.325115160</Handle>
              </Occurrence>
              <BibComments>discussion 1282–4</BibComments>
            </BibArticle>
            <BibUnstructured>Saito N, Nadgir RN, Nakahira M, Takahashi M, Uchino A, Kimura F, Truong MT, Sakai O. Posttreatment CT and MR imaging in head and neck cancer: what the radiologist needs to know. Radiographics. 2012;32(5):1261–82; discussion 1282–4.</BibUnstructured>
          </Citation>
          <Citation ID="CR47">
            <BibArticle>
              <BibAuthorName>
                <Initials>AR</Initials>
                <FamilyName>Sepahdari</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>VK</Initials>
                <FamilyName>Aakalu</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>P</Initials>
                <FamilyName>Setabutr</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Shiehmorteza</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JH</Initials>
                <FamilyName>Naheedy</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>MF</Initials>
                <FamilyName>Mafee</FamilyName>
              </BibAuthorName>
              <Year>2010</Year>
              <ArticleTitle Language="En">Indeterminate orbital masses: restricted diffusion at MR imaging with echo-planar diffusion-weighted imaging predicts malignancy</ArticleTitle>
              <JournalTitle>Radiology</JournalTitle>
              <VolumeID>256</VolumeID>
              <IssueID>2</IssueID>
              <FirstPage>554</FirstPage>
              <LastPage>64</LastPage>
              <Occurrence Type="PID">
                <Handle>20656840</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1148/radiol.10091956</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Sepahdari AR, Aakalu VK, Setabutr P, Shiehmorteza M, Naheedy JH, Mafee MF. Indeterminate orbital masses: restricted diffusion at MR imaging with echo-planar diffusion-weighted imaging predicts malignancy. Radiology. 2010;256(2):554–64.</BibUnstructured>
          </Citation>
          <Citation ID="CR48">
            <BibArticle>
              <BibAuthorName>
                <Initials>MM</Initials>
                <FamilyName>Silva</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Goldman</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>G</Initials>
                <FamilyName>Keating</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>MA</Initials>
                <FamilyName>Marymont</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>J</Initials>
                <FamilyName>Kalapurakal</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>T</Initials>
                <FamilyName>Tomita</FamilyName>
              </BibAuthorName>
              <Year>2000</Year>
              <ArticleTitle Language="En">Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy</ArticleTitle>
              <JournalTitle>Pediatr Neurosurg</JournalTitle>
              <VolumeID>33</VolumeID>
              <IssueID>3</IssueID>
              <FirstPage>151</FirstPage>
              <LastPage>8</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DC%2BD3M%2FovVWiuw%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>11096362</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1159/000028996</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Silva MM, Goldman S, Keating G, Marymont MA, Kalapurakal J, Tomita T. Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy. Pediatr Neurosurg. 2000;33(3):151–8.</BibUnstructured>
          </Citation>
          <Citation ID="CR49">
            <BibArticle>
              <BibAuthorName>
                <Initials>C</Initials>
                <FamilyName>Stannard</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>W</Initials>
                <FamilyName>Sauerwein</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>G</Initials>
                <FamilyName>Maree</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>K</Initials>
                <FamilyName>Lecuona</FamilyName>
              </BibAuthorName>
              <Year>2013</Year>
              <ArticleTitle Language="En">Radiotherapy for ocular tumours</ArticleTitle>
              <JournalTitle>Eye (Lond)</JournalTitle>
              <VolumeID>27</VolumeID>
              <IssueID>2</IssueID>
              <FirstPage>119</FirstPage>
              <LastPage>27</LastPage>
              <Occurrence Type="COI">
                <Handle>1:CAS:528:DC%2BC3sXislOrsLg%3D</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1038/eye.2012.241</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Stannard C, Sauerwein W, Maree G, Lecuona K. Radiotherapy for ocular tumours. Eye (Lond). 2013;27(2):119–27.</BibUnstructured>
          </Citation>
          <Citation ID="CR50">
            <BibArticle>
              <BibAuthorName>
                <Initials>AG</Initials>
                <FamilyName>Tyers</FamilyName>
              </BibAuthorName>
              <Year>2006</Year>
              <ArticleTitle Language="En">Orbital exenteration for invasive skin tumours</ArticleTitle>
              <JournalTitle>Eye</JournalTitle>
              <VolumeID>20</VolumeID>
              <FirstPage>1165</FirstPage>
              <LastPage>70</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DC%2BD28rovVKmsQ%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>17019414</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1038/sj.eye.6702380</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Tyers AG. Orbital exenteration for invasive skin tumours. Eye. 2006;20:1165–70.</BibUnstructured>
          </Citation>
          <Citation ID="CR51">
            <BibArticle>
              <BibAuthorName>
                <Initials>C</Initials>
                <FamilyName>Wang</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>KB</Initials>
                <FamilyName>Roberts</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>RS</Initials>
                <FamilyName>Bindra</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>VL</Initials>
                <FamilyName>Chiang</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JB</Initials>
                <FamilyName>Yu</FamilyName>
              </BibAuthorName>
              <Year>2014</Year>
              <ArticleTitle Language="En">Delayed cerebral vasculopathy following cranial radiation therapy for pediatric tumors</ArticleTitle>
              <JournalTitle>Pediatr Neurol</JournalTitle>
              <VolumeID>50</VolumeID>
              <IssueID>6</IssueID>
              <FirstPage>549</FirstPage>
              <LastPage>56</LastPage>
              <Occurrence Type="PID">
                <Handle>24739378</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1016/j.pediatrneurol.2013.09.018</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Wang C, Roberts KB, Bindra RS, Chiang VL, Yu JB. Delayed cerebral vasculopathy following cranial radiation therapy for pediatric tumors. Pediatr Neurol. 2014;50(6):549–56.</BibUnstructured>
          </Citation>
          <Citation ID="CR52">
            <BibArticle>
              <BibAuthorName>
                <Initials>JY</Initials>
                <FamilyName>Yun</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>SJ</Initials>
                <FamilyName>Kang</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JW</Initials>
                <FamilyName>Kim</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>YH</Initials>
                <FamilyName>Kim</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>H</Initials>
                <FamilyName>Sun</FamilyName>
              </BibAuthorName>
              <Year>2012</Year>
              <ArticleTitle Language="En">Osteoplastic reconstruction of post-enucleatic microorbitalism</ArticleTitle>
              <JournalTitle>Arch Plast Surg</JournalTitle>
              <VolumeID>39</VolumeID>
              <IssueID>4</IssueID>
              <FirstPage>333</FirstPage>
              <LastPage>7</LastPage>
              <Occurrence Type="PMCID">
                <Handle>3408278</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>22872836</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.5999/aps.2012.39.4.333</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Yun JY, Kang SJ, Kim JW, Kim YH, Sun H. Osteoplastic reconstruction of post-enucleatic microorbitalism. Arch Plast Surg. 2012;39(4):333–7.</BibUnstructured>
          </Citation>
        </Bibliography>
      </ChapterBackmatter>
    </Chapter>
  </Book>
</Publisher>
